CV Col. Medic Dr. Octavian Vasiliu Mai 2020

CURRICULUM VITAE
Octavian Vasiliu
Data şi locul nașterii

16.04.1974, Bucureşti
Pregătire profesională
Instituția de învățământ Tipul diplomei Durata studiilor

Universitatea de Licență 1992-1998
Medicină şi Farmacie
"Carol Davila" Bucureşti,
Facultatea Medicină
Generală
Universitatea Bucureşti, Licență 2000-2004
Facultatea de Psihologie şi
Ştiinţele Educaţiei,
specializarea Psihologie
Universitatea Masterat 2003-2005
Titu Maiorescu, București, Psihoterapie cognitiv-comportamentală
Facultatea de Psihologie (coordonator Prof. Univ.dr.
Irina Holdevici)
Universitatea Bucureşti, Masterat Neurobiologie 2004-2006
Facultatea de Biologie (coordonator Prof.Univ.dr.
Maria Luiza Flonta)
Universitatea București, Doctorat Psihologie 2006-2009
Facultatea de Psihologie (coordonator Prof.Univ.dr.
Nicolae Mitrofan)
Universitatea de Medicină Doctorat Științe Medicale 2010-2016
și Farmacie (coordonator Acad.Prof.Univ.dr.
“Carol Davila” București, Victor A. Voicu)
Facultatea de
Medicină Generală
Stagii de pregătire profesională și specializări

-un an de stagiu în medicină generală (1999) desfășurat în Spitalul Universitar de
Urgenţă Militar Central ”Dr. Carol Davila”, Bucureşti;
-rezidenţiat în Psihiatrie desfăşurat în Clinica de Psihiatrie a Spitalului Universitar
de Urgenţă Militar Central ”Dr. Carol Davila” (2000-2005);
-rezidențiat în Farmacologie clinică desfășurat în Clinica Toxicologie- ATI a
Spitalului Clinic de Urgență București (2015-2019);
-psihoterapeut cu drept de practică independentă, specializat în terapie cognitiv-
comportamentală, certificat de Colegiul Psihologilor din România începând cu anul 2011;
-psiholog clinician specialist, certificat de Colegiul Psihologilor din România
începând cu anul 2011;
-curs de specializare în Psihooncologie prin programul internațional "Enseignement
postuniversitaire de psychooncologie" (coord. Prof.dr. J. Fr. Allilaire si Prof.dr. I. Popescu)-
Bucuresti, 2002- 2003, lucrare de absolvire cu tema "L'importance des mecanismes de
defense au patients oncologiques";
-curs de formare în asistenţa psihiatrică a toxicomanilor- organizat de Jellinek
EATI şi ONG ALIAT, Bucureşti, septembrie 2003 - iunie 2004;
1
-curs de formare profesională pentru formatori, Fundația Euroacademica, Buzău,
2012, certificat de absolvire recunoscut de Ministerul Muncii, Familiei și Protecției Sociale și
Ministerul Educației, Cercetării, Tineretului și Sportului din România;
-formare în domeniul meta-analizelor, studiilor clinice și colectării de bune
practici în domeniul drogurilor ilicite, alcoolului și dependenței furnizată de Institutul
Național de Sănătate și Bunăstare (THL) din Helsinki, Finlanda, 2009;
-formare în domeniul expertizei psihiatrice medico-legale prin programe de
pregătire post-doctorale - „Standarde europene pentru programe postdoctorale competitive
de formare în domeniul managementului cercetării avansate şi expertizei psihiatrice medico-
legale”, program desfăşurat de Centrul de Cercetare Avansată Bucureşti, în perioada
ianuarie-iunie 2011 și ”Standarde europene pentru programe postdoctorale competitive de
formare în domeniul managementului cercetării avansate şi expertizei psihiatrice medico-
legale”, program desfăşurat de Centrul de Cercetare Avansată Iași, în perioada aprilie 2012-
aprilie 2013;
-formare în management sanitar finalizată prin „Atestat în managementul
serviciilor de sănătate” (2009-2010), Școala Națională de Sănătate Publică și Management
Sanitar, certificat eliberat în baza OM 840/4.845/2006;
-formare în Psihofarmacologie clinică prin Master Psychopharmacology Program
susținut de Neurocience Education Institute, acreditat de US Accreditation Council for
Continuing Medical Education și American Board of Psychiatry and Neurology (2019).
Funcții ocupate
-medic specialist psihiatru, martie 2005- iunie 2010, Spitalul Universitar de Urgenţă
Militar Central, Secția Clinică Psihiatrie;
-medic primar psihiatru, din iulie 2010, Spitalul Universitar de Urgenţă Militar
Central, Secția Clinică Psihiatrie.
Stagii, workshop-uri şi cursuri postuniversitare finalizate

-"Orientări actuale psihofarmacologice în tratamentul schizofreniei" (coordonator
Prof.Dr. M.D.Gheorghe), Bucureşti, iunie 2000;
-"Psihofarmacologia tulburărilor depresive" (coordonator Prof. Dr. M. D. Gheorghe),
Bucureşti, aprilie 2000;
-"Schizofrenia- baze neurobiologice şi psihofarmacologice (coordonator Prof. Dr. M.
D. Gheorghe), Bucureşti, octombrie 2000;
-"Anticonvulsivantele- medicamente cu acţiune polivalentă. Noi perspective
terapeutice în neurologie şi psihiatrie" (coordonator Prof. Dr. M.D.Gheorghe), Bucureşti,
septembrie 2000;
-"Mit şi realitate despre mecanismul dependenţei la benzodiazepine" (coordonator dr.
Irina Dan si dr. Vasile Daniel), Bucureşti, octombrie 2003;
-"Programul educaţional pentru tulburările de somn- Somnul şi sanatatea"
(coordonator Prof. dr. Ovidiu Bajenaru), Bucureşti, martie 2003;
-"Noi abordări terapeutice în adicţii şi alcoolism"(I) (coordonator program Dr. Wim
Buisman- Institutul Jellinek și Conf. dr. Dan Prelipceanu) în ianuarie 2002, Bucureşti;
-"Abordări terapeutice în adicții și alcoolism"(II) (coordonator program Dr. Wim
Buisman- Institutul Jellinek și Conf. dr. Dan Prelipceanu) în martie 2002, Bucureşti;
-"EEG, EMG şi potențiale evocate" (coordonator Prof.dr. D. Constantin), Bucureşti,
aprilie 2003;
-"Actualități în diabetul zaharat şi sindromul X metabolic" (coordonatori Prof.dr.
M.Cinteza si Prof.dr. M.Vintila), Bucureşti, decembrie 2002;
-„Noi orizonturi terapeutice în demenţe”, simpozion organizat de Asociația Româna
de Psihofarmacologie si Societatea de Neurologie din România, Bucureşti, mai 2004 ;
-„Interactive Educational Course for Young Psychiatrists and Researchers”, organizat
de ECNP, Poiana Braşov, aprilie 2005;
2
-“Profilul farmacologic al antidepresivelor moderne”, Bucureşti, 2005;
-"Bazele terapiilor scurte, colaborative, orientate pe soluţii (trainer C.I.Bogdan,
supervizare Irina Holdevici) în perioada noiembrie 2001- iunie 2002, Bucureşti;
-"Tehnici proiective de desen" (trainer psih. Anca Preda), mai 2002, București;
-"Zilele adleriene de primavară- Psihoterapie şi consiliere adleriana" (trainer Francis
X. Walton), mai 2003, Bucureşti;
-“ Aspecte clinice fundamentale ale tulburării afective bipolare”, Bucureşti, 2008;
-“Wounds of war: lowering suicide risk in returning troops”, Austria, 2007;
-“Algorithms of change”, Bucureşti, 2007;
-“Noi abordări terapeutice în tratamentul psihiatric“, Bucureşti, 2008;
-“Progress in depression: new developments in short term management and patient
care”, Barcelona, 2008;
-“Addressing the unmet needs of our depressed patients”, Barcelona, 2008;
“New advances for patients with bipolar disorder: a focus on the latest clinical trial
data”, Barcelona, 2008;
-“Bipolar disorder: from randomized controlled trials to observational studies- lessons
for clinical practice”, Barcelona, 2008;
-“Long term management of bipolar disorder”, Barcelona, 2008;
-„Actualităţi clinice şi farmacologice în tulburarea depresivă majoră”, Bucureşti,
2008;
-„Schizofrenie- istoric, particularităţi etio-patogernice, de diagnostic, clinice şi
terapeutice”, Bucureşti, 2008;
-„Elaborarea de meta-analize şi colectarea de bune practici în domeniul adicţiilor”,
Braşov, iulie 2009;
-„Neurobiologia depresiei”, București, Spitalul Al.Obregia, aprilie-iunie 2010;
-„Curs de Neuroimagistica”, Societatea Romana de Alzheimer, București, 2012;
-„Sesiune de formare a grupului de cercetare în bune practici în domeniul adicțiilor”,
Proiect de înfrățire instituțională PHARE RO/2006/IB/JH-07-„Consolidarea Sistemului
Integrat de Asistență Medicală, Psihologică și Socială pentru Consumatorii de Droguri din
România”, București, iunie, 2009;
-„Introducere în psihofarmacologie clinică- partea 1”, coordonator Conf.dr. Daniel
Vasile, 24 martie 2015;
-“Clinical Hypnosis, relaxation and meditation in therapy. Possibilities and action
limits”, Teodor Vasile, 21-22 octombrie 2016, București;
-“Model de intervenție treptată hipnoterapeutică în tulburările sexuale psihogene”,
Irina Holdevici, Barbara Craciun, 21-22 octombrie 2016, București;
-“Evaluarea, consilierea și psihoterapia experiențială a copilului, adultului, cuplului și
familiei. Modulul Evaluarea clinică a copilului prin metode validate științific”, Institutul de
Psihologie a Dezvoltării, 10 decembrie 2016;
-“Actualități în evaluarea și redactarea protocolului de examen psihologic specific
comisiilor medico-legale psihiatrice aflate în cadrul IML-urilor”, curs organizat de
AIPADSM, București, 16 septembrie 2017;
-“Tulburări disruptive, de control al impulsurilor și de conduită la copil și adolescent:
comorbiditate, strategii de psihodiagnostic și intervenție clinică și educațională”, Institutul de
Psihologie a Dezvoltării, 23 septembrie 2017;
-”Teste proiective”, trainer psih. Elena Cozma, 10 februarie 2018, București;
-„Tulburările anxioase și depresive la adult: conceptualizarea cazului și model de
intervenție psihoterapeutică”, Institutul de Psihologia Dezvoltării, 28-29 septembrie 2019,
Brasov;
-“Hiperactivitatea cu deficit de atenție: evaluare clinică și educațională, diagnostic
diferențial și program de intervenție”, Institutul de Psihologia Dezvoltării, 18-19 ianuarie
2020, București;
3
-„Introduction to Cognitive Behavioural Therapy”, European Psychiatric Association,
30 May 2020;
-„Introduction to Motivational Interviewing”, European Psychiatric Association, 6
June 2020;
-„Dislexia, disgrafia si discalculia la copil: strategii de psihodiagnostic clinic si
interventie educationala”, Institutul de Psihologia Dezvoltării, iulie 2020.
Participări la congrese naţionale şi internaţionale cu tematică medicală

-7th Regional Meeting of the European College of Neuropsychopharmacology -
Bucureşti (aprilie 2002)
-16th ECNP Congress- Praga (septembrie 2003)
-Achieving remission in the depressed patient treating both the emotional and the
physical symptoms”, simpozion satelit al "16th ECNP Congress- Praga (septembrie 2003)
-New options in the management of Alzheimer’s disease, simpozion satelit al "16 th
ECNP Congress"- Praga (septembrie 2003)
-Al 6-lea Congres National de Istoria Medicinei- Bucureşti (iunie 2002)
-Al III-lea Simpozion Național al Asociației Române a Disfuncției Erectile-
Bucureşti, 2003
-Al IV-lea Simpozion Național de Istoria Psihiatriei, Bucureşti, 2004
-Terapie si management in psihiatrie- Conferinţa Naţională de Psihiatrie organizată de
Asociaţia Psihiatrică Romană şi World Psychiatric Association, Craiova, septembrie 2004
-A 14-a Conferinţa Naţionala de Epilepsie, Bucureşti, 2005
-Al 9-lea Congres Naţional al Asociatiei Medicilor Rezidenți în Psihiatrie din
România, Bucureşti, 2005
-Interactive educational course for young psychiatrists and researchers, Poiana
Braşov, 2005
-Students and young Doctors 1st European Congress of Military Medicine, Bucuresti,
2005
-19th ECNP Congress, Paris, 2006
-A 6-a Conferinţă Natională de Aterotromboză, Bucureşti, 2006
-Primul Congres Naţional al Asociației de Endocrinologie Clinică din Romania,
Brăila, 2006
-11th Congress of Balkan Military Medical Committee, Atena, 2006
-15th European Congress of Psychiatry, Madrid, 2007
-Forumul de Psihiatrie, Bucureşti, 2007
-8th International Psychiatry Forum – Mind Matters, Bucureşti, 2007
-A 8-a Conferință Națională de Aterotromboză, Bucureşti, 2008
-Forumul Național de Psihiatrie, Sinaia, 2008
-Cybertherapy 12th Conference : trasforming healthcare through technology,
Washington, 2008
-21st ECNP Congress, Barcelona, 2008
-National Guard Trained Crisis Responder (TCR) Course: Terrorism and Disaster
Response, București, 2010
-Zilele Spitalului Universitar de Urgență Militar Central, București, septembrie 2011
-Al 55-lea Conges Național de Cardiologie, Sinaia, septembrie 2016
-A X-a Conferință Națională de Psihiatrie Biologică și Psihofarmacologie, Craiova,
martie 2017
-Congresul Universității de Medicină și Farmacie Carol Davila București, ediția a V-
a, mai 2017
-Al 56-lea Conges National de Cardiologie, Sinaia, septembrie 2017
-A XI-a Conferință Națională de Psihiatrie Biologică și Psihofarmacologie cu
Participare Internațională, Craiova, aprilie 2018
-Al 57-lea Conges National de Cardiologie, Sinaia, septembrie 2018
4
-Conferința Anuală a Spitalului Universitar de Urgență Militar Central «Dr. Carol
Davila», București, octombrie 2018
-The 23rd Congress of the World Association of Social Psychiatry, Bucharest, 2019.
Participări la conferinţe şi congrese de Psihologie

-Conferinţa Naţională de Psihologie, Cluj-Napoca, 2006
-Centenarul psihologiei la Universitatea București, conferință internațională,
București, 2006
-Congresul Internațional de Psihologie ”Cercetarea psihologică modernă- Direcţii şi
perspective”, Sibiu, 2007
-Conferința Naţională de Psihologie „Dialog pentru diversitate”, Timişoara, 2008
-The International Conference “Psychology and the realities of the contemporary
world” 7th Ed., București, 2016
-Conferința “Aplicații practice în dezvoltarea psihologiei”, ed. a VI-a, Asociația
Smart Psi, București, 2016
-Congresul Internațional de Psihologie ”Cercetarea modernă în psihologie”, ed. a XII-
a, Sibiu, 2018
-Conferința “Aplicații practice în dezvoltarea psihologiei”, ed. a VIII-a, Asociația
Smart Psi, București, 2018.
-Conferința “Aplicații practice în dezvoltarea psihologiei”, ed. a IX-a, Asociația
Smart Psi, București, 2019.
Lucrări indexate Thomson Reuters - Web of Science Core Collection - în rezumat

1. Vasile D, Vasiliu O, Baloescu A, Grigorescu G. Reboxetine in the treatment of
elderly inpatients with major depressive disoder. 7th Regional Meeting of the European
College of Neuropsychopharmacology. European Neuropsychopharmacology 2002;12(2):41
2. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. Drug monitoring factors in
schizophrenia treatment. 17th ECNP Congress. European Neuropsychopharmacology
2004;14(Suppl.3):S246.
3. Vasile D, Gheorghe M, Vasiliu O. Sexual dysfunctions in patients with depression
treated with SSRI. A therapeutic approach. 12th AEP Congress. European Psychiatry
2004;19(Suppl.1): 215S.
4. Vasile D, Gheorghe MD, Vasiliu O, Apetroaei A, Paraschiv S. Clinical course
features in first episode schizophrenia in young male. 4th International Conference on Early
Psychosis. Schizophrenia Research 2004;70(1, Supplement):113.
5. Vasile D, Gheorghe MD, Vasiliu O, Apetroaei A, Paraschiv S. Side effects of
atypical antipsychotics in first episode of schizophrenia in young males. 4th International
Conference on Early Psychosis. Schizophrenia Research 2004;70(1, Supplement):145.
6. Vasile D, Gheorghe M, Vasiliu O. Analgesic effect of trazodone in neoplasm
associated pain. European Psychiatry 2004;19 (Suppl.1):233S.
7. Vasile D, Gheorghe M, Vasiliu O, Paraschiv SL. The efficacy of amisulpride on
negative symptoms in chronic schizophrenia. 24th CINP Congress. International Journal of
Neuropsychopharmacology 2004;7(Suppl.1):S410.
8. Vasile D, Gheorghe MD, Vasiliu O. Efficacy of bupropion in alcohol dependent
patients with major depressive episode. 18th ECNP Congress. European
Neuropsychopharmacology 2005;15(Suppl.3):S400
9. Vasile D, Gheorghe MD, Vasiliu O, Baloescu A. Parenteral administration of
olanzapine for schizophrenic patients with aggressive behaviour. 18th ECNP Congress.
European Neuropsychopharmacology 2005;15(Suppl.3):S466
10. Vasile D, Gheorghe M, Vasiliu O, Lungut E. Psychopathological and somatic
comorbidity in major depressive disorders. European Psychiatry 2005;20 (Suppl.1):S147.
5
11. Vasiliu O, Vasile D, Miclos M, Ivanov P. Antidepressant switch efficacy in SSRI
resistant major depressive disorder. 19th ECNP Congress. European
Neuropsychopharmacology 2006;16(4):S324
12. Vasiliu O, Vasile D, Paraschiv S, Miclos M, Ivanov P. Amisulpride association to
SSRI in severe major depressive episodes with psychotic features. 19th ECNP Congress.
European Neuropsychopharmacology 2006;16(4):S362
13. Gheorghe MD, Voicu V, Vasile D, Vasiliu O. Negative and cognitive
symptomatology improvement during Aripiprazole treatment in chronic schizophrenia. 19th
ECNP Congress. European Neuropsychopharmacology 2006;16(4):S409-410
14. Vasile D, Vasiliu O, Ojog D, Gheorghe MD. Risperidone long-acting IM
formulation in high risk of noncompliance bipolar patients. 19th ECNP Congress. European
Neuropsychopharmacology 2006;16(4):S413-414
15. Vasile D, Vasiliu O, Paraschiv S, Ivanov P, Terpan M, Vasile M. Metabolic
adverse events of antipsychotics treatment in chronic schizophrenia. 15th European Congress
of Psychiatry. European Psychiatry 2007;22:S170-171
16. Vasile D, Vasiliu O, Ivanov P, Ojog D, Sarmache M, Vasile M. Venlafaxine XR
versus fluoxetine in the treatment of major depressive disorder and generalized anxiety
disorder dual diagnosis. 15th European Congress of Psychiatry. European Psychiatry
2007;22:S247
17. Vasile D, Vasiliu O, Ojog D, Vasile M, Sarmache M, Terpan M. Augmenting
antidepressant psychopharmacological approach with cognitive behavioural therapy in
bipolar depression. 15th European Congress of Psychiatry. European Psychiatry
2007;22:S261
18. Vasile D, Vasiliu O, Vasile M, Sarmache M, Terpan M. Nonbenzodiazepine
versus benzodiazepine hypnotic efficiency analysis in older people. 15th European Congress
of Psychiatry. European Psychiatry 2007;22:S289
19. Vasile D, Vasiliu O, Sarmache M, Terpan M, Ojog D. Augmenting
psychopharmacological treatment with cognitive behavioural therapy in major depressive
disorder with alcohol dependence dual diagnosis. DP-02-02. 39th International Danube
Symposium for Neurological Sciences and Continuing Education in conjunction with the 1st
International Congress on ADHD from childhood to adult disease, 2-5 june 2007, Wurzburg.
Journal of Neural Transmission 2007;114(7):CXIX
20. Vasile D, Vasiliu O, Paraschiv S, Vasile M, Brisculescu R. Intramuscular
olanzapine efficiency in the accute treatment of schizoaffective disorder. DP-02-04. 39th
International Danube Symposium for Neurological Sciences and Continuing Education in
conjunction with the 1st International Congress on ADHD from childhood to adult disease,
2-5 june 2007, Wurzburg. Journal of Neural Transmission 2007;114(7):CXIX
21. Vasile D, Vasiliu O, Paraschiv S, Vasile M, Terpan M. Intramuscular and
orodispersable olanzapine efficiency in the acute treatment of manic episodes. 20th ECNP
Congress. European Neuropsychopharmacology 2007;17(4):S430-431.
22. Vasile D, Vasiliu O, Miclos M, Ivanov P, Sarmache M. Combined atipical
antipsychotics and valproate sodium approach in the bipolar I disorder maintenance
treatment. 20th ECNP Congress. European Neuropsychopharmacology 2007;17(4):S431
23. Vasile D, Vasiliu O, Paraschiv S, Ojog D, Vasile M. Combined antidepressants
and quetiapine therapy in bipolar depression with psychotic features – an open labeled study.
20th ECNP Congress. European Neuropsychopharmacology 2007;17(Suppl.4):S487.
24. Vasile D, Vasiliu O, Ivanov P, Sarmache M, Terpan M. Combined pregabalin and
selective serotonin reuptake inhibitors in ajustement disorders with anxiety. 20th ECNP
Congress. European Neuropsychopharmacology 2007;17(4):S517
25. Vasile D, Vasiliu O, Ivanov P, Terpan M, Patriche D, Ojog D. Atypical
antipsychotics in the treatment of non-cognitive symptoms of Alzheimer dementia. 12th
Congress of the European Federation of Neurological Societies. European Journal of
Neurology 2008;15(Suppl.3):233-234.
6
26. Vasile D, Vasiliu O, Cretu O, Patriche, Bancescu R, Stanescu B. Efficacy of
tianeptine in the treatment of post-stroke depression. 12th Congress of the European
Federation of Neurological Societies. European Journal of Neurology 2008;15(Suppl.3):267.
27. Vasile D, Vasiliu O, Ivanov P, Stanescu B, Terpan M, Bancescu R. Therapeutic
management of interictal dysphoria in epilepsy. 12th Congress of the European Federation of
Neurological Societies. European Journal of Neurology 2008;15(Suppl.3):315.
28. Vasiliu D, Vasiliu O, Tudor C, Ungureanu D, Cretu O, Terpan M. Aripiprazole
switch-on in chronic schizophrenia with atypical antipsychotics associated weight gain. 21st
ECNP Congress. European Neuropsychopharmacology 2008;18(Suppl.4):S446
29. Vasiliu D, Vasiliu O, Tudor C, Patriche D, Stanescu B, Ojog D. Venlafaxine
versus selective serotonin reuptake inhibitors in mixed major depression and dysthymic
disorder. 21st ECNP Congress. European Neuropsychopharmacology
2008;18(Suppl.4):S310-311.
30. Vasile D, Vasiliu O, Patriche D, Stanescu B, Bancescu R. Oral risperidone
efficacy in Alzheimer Dementia with psychotic features. The International Journal of
Neuropsychopharmacology 2008; 11 (Suppl.1);176
31. Vasile D, Vasiliu O, Vasile M, Cretu O, Ojog D. Bupropion SR augmentation
strategy in mirtazapine major depressive disorder incomplete responders. 26th CINP
Congress. The International Journal of Neuropsychopharmacology 2008; 11 (Suppl.1):176
32. Vasile D, Vasiliu O, Vasile M, Cretu O, Terpan M. Serotoninergic combos in
treatment resistant depressive disorder. 26th CINP Congress. The International Journal of
Neuropsychopharmacology 2008; 11 (Suppl.1):176
33. Vasile D, Vasiliu O, Vasile M, Cretu O, Ojog D. The switch on trazodone in
major depressive disorder with significant weight gain. 26th CINP Congress. The
International Journal of Neuropsychopharmacology 2008; 11 (Suppl.1):207
34. Vasile D, Vasiliu O, Stanescu B, Bancescu R, Terpan M. The efficacy of
venlafaxine vs. SSRIs in panic disorder and major depressive disorder dual diagnosis. 26th
CINP Congress. The International Journal of Neuropsychopharmacology 2008; 11
(Suppl.1):284-285.
35. Vasile D, Vasiliu O, Vasile M, Terpan M, Brisculescu R. Improving the quality of
life in patients with malignant tumors using cognitive psychotherapy. 16th European
Congress of Psychiatry. European Psychiatry 2008;23(Suppl.2):S302-303.
36. Vasile D, Vasiliu O, Ojog D, Brisculescu R, Vasile M. Cognitive-behavioural
therapy efficacy in major depressive disorder and histrionic personality disorder dual
diagnosis. 16th European Congress of Psychiatry. European Psychiatry
2008;23(Suppl.2):S302.
37. Vasile D, Vasiliu O, Ivanov P, Vasile M, Terpan M. Alzheimer dementia
associated cognitive and non-cognitive symptoms evolution during Donepezil treatment. 16th
European Congress of Psychiatry. European Psychiatry 2008;23(Suppl.2):S199.
38. Vasile D, Vasiliu O, Ivanov P, Terpan M, Paraico I. Alteration of body image
perception as a side event of antipsychotic treatment in schizophrenic patients. 16th
39. Vasile D, Vasiliu O, Vasile M, Terpan M, Paraico I. Coping mechanisms
evaluation in chronic schizophrenic patients. 16th European Congress of Psychiatry.
European Psychiatry 2008;23(Suppl.2):S151.
40. Vasile D, Vasiliu O, Vasile M, Terpan M. Tolerability of rivastigmine transdermal
patch in Alzheimer dementia with psychotic features. 22nd ECNP Congress. European
Neuropsychopharmacology 2009;19(3):S622-623.
41. Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Stanescu B, Petrescu BM,
Nastase DM, Bogdan V. Quality of life improvement through depression treatment in
oncologic patients. 18th European Congress of Psychiatry. European Psychiatry
2010;25(Suppl.1):997.
7
42. Vasile D, Vasiliu O, Bogdan V, Badescu E, Mangalagiu AG, Stanescu B, Petrescu
BM. The efficacy of psychopharmacologic treatment in depressive disorder associated with
Parkinson’s disease dementia. 18th European Congress of Psychiatry. European Psychiatry
2010;25(Suppl.1):996.
43. Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Badescu E, Petrescu BM,
Bogdan V, Ojog DG. The influence of the conflicting paradigms over the prognosis in major
depressive disorder. 18th European Congress of Psychiatry. European Psychiatry
2010;25(Suppl.1):224.
44. Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Stanescu B, Terpan M, Nastase
DM, Petrescu BM, Bogdan V. Treatment strategies for the management of the self-agressive
manifestations in heroin dependence. 18th European Congress of Psychiatry. European
Psychiatry 2010;25(Suppl.1):1667.
45. Vasile D, Vasiliu O, Mangalagiu AG, Vasile ML, Badescu E, Bogdan V, Terpan
M, Ojog DG, Petrescu BM. Addressing self-image distorsions as a core feature in the alcohol
dependence psychotherapeutic approach. 18th European Congress of Psychiatry. European
Psychiatry 2010;25(Suppl.1):1678.
46. Grigorescu G, Vasile D, Vasiliu O, Vasile ML, Tudor C, Cantemir A, Zavoianu
M, Mangalagiu AG, Terpan M, Grigorescu R. Amisulpride augmentation vs. standard
antidepressant therapy in major depressive disorder. XXVII CINP Congress. International
Journal of Neuropsychopharmacology 2010;13:149
47. Vasile D, Vasiliu O, Terpan M, Vasile ML, Tudor C, Bogdan V, Mangalagiu AG,
Grigorescu G, Ojog D. Low doses risperidone in cluster A personality disorder- a prospective
study. XXVII CINP Congress. International Journal of Neuropsychopharmacology
2010;13:110
48. Vasile D, Vasiliu O, Tudor C, Vasile ML, Grigorescu G, Bogdan V, Terpan M,
Mangalagiu AG, Petrescu MB, Ojog D. Galantamine switch in donepezil non-responsive
patients with early-onset Alzheimer dementia. XXVII CINP Congress. International Journal
of Neuropsychopharmacology 2010;13:141
49. Grigorescu G, Baloescu A, Vasile D, Tudor C, Vasiliu O, Grigorescu R. Standard
antidepressant therapy vs association between amisulpride and antidepressant theray in
atypical depression. 23rd ECNP Congress. European Neuropsychopharmacology
2010;20:149.
50. Vasile D, Vasiliu O, Vasile ML, Terpan M, Mangalagiu A, Bogdan V, Ojog D,
Petrescu MB, Paraico I. Influences between defense mechanisms and antidepressants on the
therapeutic compliance in major depressive disorder. 23rd ECNP Congress. European
Neuropsychopharmacology 2010;20:S343-S344
51. Vasile D, Vasiliu O, Vasile ML, Terpan M, Grigorescu G, Bogdan V, Mangalagiu
A, Petrescu MB, Ojog D. Comparative efficacy of cholinesterase inhibitors in dementia
associated with Parkinson’s disease. 23rd ECNP Congress. European
Neuropsychopharmacology 2010;20:S553-S554.
52. Vasile D, Vasiliu O, Vasile M.L, Terpan M, Ojog DG. Agomelatine versus
selective serotoninergic reuptake inhibitors in major depressive disorder and comorbid
diabetes mellitus. 24th Congress Meeting of ECNP. European Neuropsychopharmacology
2011;21(Suppl.3):S383-384.
53. Tudor C, Cantemir A, Grigorescu G, Vasiliu O, Vasile D, Zavoianu M. Efficacy
and safety of duloxetine in patients with melancholic depression. 24th Congress Meeting of
ECNP. European Neuropsychopharmacology 2011;21(Suppl.3):S388.
54. Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Bogdan V, Paraico I. Cognitive
behavioral therapy focused upon communicational skills enhancement in anorexia nervosa- a
case series. 19th European Congress of Psychiatry. European Psychiatry 2011;26
(Suppl.1):P02-144.
8
55. Vasile D, Vasiliu O, Vasile B, Tudor C, Mangalagiu AG, Ojog DG. Valproate and
cognitive therapy combined treatment efficacy in pathological gambling. 19th European
Congress of Psychiatry. European Psychiatry 2011;26(Suppl.1):P03-121.
56. Vasile D, Vasiliu O, Tudor C, Bogdan V, Mangalagiu AG, Vasile ML, Terpan M.
Therapeutic efficacy of duloxetine versus selective serotonin reuptake inhibitors in irritable
bowel syndrome. 19th European Congress of Psychiatry. European Psychiatry
2011;26(Suppl.1):P03-122.
57. Vasile D, Vasiliu O, Grigorescu G, Mangalagiu AG, Ojog DG, Bogdan V.
Incidence of axis I and II dual diagnosis in hospitalized patients with somatization disorder.
19th European Congress of Psychiatry. European Psychiatry 2011;26(Suppl.1):P03-405
58. Vasile D, Vasiliu O, Mangalagiu AG, Banica A, Stanescu B, Blandu M.
Naltrexone efficacy in alcohol dependence with comorbid axis II diagnosis. 20th European
Congress of Psychiatry. European Psychiatry 2012;27(Suppl.1):P-101.
59. Vasile D, Vasiliu O, Mangalagiu AG, Banica A, Taina NF, Blandu M.
Comparative analysis of dual serotonergic and noradrenergic antidepressants in double
depression with alcohol dependence. 19th European Congress of Psychiatry. European
Psychiatry 2012;27(Suppl.1):P-537.
60. Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Banica A. Quality of life
assessment in colon malignant tumors associated depression during trazodone treatment. 19th
European Congress of Psychiatry. European Psychiatry 2012;27(Suppl.1):P-826.
61. Vasile D, Vasiliu O, Mangalagiu AG, Banica A, Taina NF, Stanescu B.
Improvement of prognosis through long acting risperidone versus combined adherence
focused psychotherapy and oral antipsychotics in chronic schizophrenia. 19th European
Congress of Psychiatry. European Psychiatry 2012;27(Suppl.1):P-1323.
62. Vasile D, Vasiliu O, Mangalagiu AG, Nanca A. Pharmacological management of
affective symptoms after primary hepatic tumor surgery. 28th CINP World Congress of
Neuropsychopharmacology. International Journal of Neuropsychopharmacology
2012;15(Suppl.1):198.
63. Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Nanca A. Comparative efficacy
of cholinesterase inhibitors in dementia associated with Parkinson’s disease. 28th CINP
World Congress of Neuropsychopharmacology. International Journal of
Neuropsychopharmacology 2012;15(Suppl.1):174.
64. Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Nanca A. Quality of life
assessment in fibromyalgia during duloxetine treatment. 28th CINP World Congress of
2012;15(Suppl.1):157.
65. Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Nanca A, Ojog DG.
Comparative analysis of agomelatine and selective serotoninergic reuptake inhibitors in
major depressive disorder with severe anxiety features. 28th CINP World Congress of
2012;15(Suppl.1):156-157.
66. Vasile D, Vasiliu O, Blandu M, Ojog DG. Naltrexone effectiveness in alcohol
dependence with comorbid cluster B personality disorders. 28th CINP World Congress of
2012;15(Suppl.1):77.
67. Vasile D, Vasiliu O, Tudor C, Mangalagiu AG, Magazin O, Sopterean GA, Bratu
RE. Comparative analysis of agomelatine and trazodone in late-onset major depression. 26th
ECNP Congress. European Neuropsychopharmacology 2013;23(Suppl.2):S319-20
68. Vasile D, Macovei RA, Vasiliu O. Efficacy and tolerability of bupropion in major
depressive disorder associated with Parkinson’s disease. 26th ECNP Congress. European
Neuropsychopharmacology 2013;23(Suppl.2):S322-23
9
69. Vasile D, Vasiliu O, Sopterean GA, Bratu RE. Mirtazapine versus sertraline in the
treatment of post-psychotic depression. 26th ECNP Congress. European
70. Vasile D, Vasiliu O, Tudor C, Mangalagiu AG, Petrescu BM, Sopterean GA,
Bratu RE. Pharmacological management of alcohol dependence in chronic schizophrenia.
26th ECNP Congress. European Neuropsychopharmacology 2013;23(Suppl.2):S429
71. Vasile D, Macovei RA, Vasiliu O, Ojog DG. A multicentric, retrospective data
collection from patients diagnosed with schizophrenia switched to amisulpride- SWITCH
study. 26th ECNP Congress. European Neuropsychopharmacology 2013;23(Suppl.2):S501-2
72. Vasile D, Macovei RA, Vasiliu O, Mangalagiu AG, Tudor C. Evolution of
addictive comorbidities in a group of patients diagnosed with schizophrenia during atypical
antipsychotic treatment. 21st European Congress of Psychiatry. European Psychiatry
2013;28(1):1127
73. Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Magazin O. The efficacy of
social skills training over self-image distorsions in avoidant personality disorder. 21st
European Congress of Psychiatry. European Psychiatry 2013;28(1):1126
74. Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM. Characteristics of the
antipsychotic switch to amisulpride in schizophrenia in Romanian practice- a multicentric,
retrospective data collection (SWITCH study). 21st European Congress of Psychiatry.
European Psychiatry 2013;28(1):1125
75. Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM. A multicentric, retrospective
data collection from patients diagnosed with schizophrenia switched to Solian® in Romanian
practice- SWITCH study. 21st European Congress of Psychiatry. European Psychiatry
2013;28(1):1124
76. Vasile D, Vasiliu O, Sopterean GA, Bratu RE, Androne F, Vasile F. Effectiveness
and tolerability of nalmefene in alcohol use dependence comorbid with schizophrenia. 27th
ECNP Congress. European Neuropsychopharmacology 2014;24(2):S538.
77. Vasile D, Macovei RA, Vasiliu O, Vasile F. Pharmacologic treatment strategies in
premenstrual dysphoric disorder. ECNP Congress. European Neuropsychopharmacology
2014;24(2):S481.
78. Petrescu B, Vasile D, Vasiliu O, Tudor C, Mangalagiu A, Ungureanu D. SSRI
dose escalation versus duloxetine in treatment of major depressive disorder not responding to
initial SSRI. 27th ECNP Congress. European Neuropsychopharmacology 2014;24(2):S455-
456.
79. Vasile D, Macovei RA, Vasiliu O, Vasile F, Ojog DG. Efficacy and tolerability of
agomelatine switch in patients with sexual dysfunctions treated with serotonin selective
reuptake inhibitors. 27th ECNP Congress. European Neuropsychopharmacology
2014;24(2):S395.
80. Vasile D, Vasiliu O, Bratu RE, Sopterean GA, Vasile F, Ojog DG. Comparative
analysis of pregabalin and buspirone as adjunctive agents in major depressive disorder
partially responsive to SSRIs. 27th ECNP Congress. European Neuropsychopharmacology
2014;24(2):S389.
81. Vasile D, Vasiliu O, Bratu ER, Sopterean GA, Androne F, Vasile F. Analysis of
trazodone and pregabalin in neurocognitive disorders with psychomotor agitation. 23rd
European Congress of Psychiatry. European Psychiatry 2015;30(Suppl.1):1464.
82. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Affective symptoms as prognosis
factor in schizophrenia. 23rd European Congress of Psychiatry. European Psychiatry
2015;30(Suppl.1):1739.
83. Petrescu B, Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Ungureanu D. A
comparative prospective study of agomelatine versus escitalopram in treatment of severe
major depressive disorder. 28th ECNP Congress. European Neuropsychopharmacology
2015;25(Suppl.2):S439.
10
84. Vasile D, Vasiliu O, Bratu-Bazic RE, Androne FT, Patrascu M, Alboae AF,
Moraru EA, Candea C. Therapeutic management of obesity in patients who gained weight
during antidepressant treatment. 29th ECNP Congress. European Neuropsychopharmacology
2016;26(Suppl.2):S475-476.
85. Vasiliu O, Vasile D, Androne F, Patrascu M, Morariu E. Between creativity and
death: Abstract expressionists and alcohol use disorders. 25th European Congress of
Psychiatry. European Psychiatry 2017;41(Suppl.1):S519.
86. Vasiliu O, Vasile D, Vasiliu DG, Andreea Filareta A. Quetiapine XR as add-on to
antidepressants in treatment-resistant late-life major depression. 25th European Congress of
87. Vasile D, Vasiliu O. Cognitive-behavioral therapy in young adults with major
depression and alcohol dependence. 25th European Congress of Psychiatry. European
Psychiatry 2017;41(Suppl.1):S397.
88. Vasile D, Vasiliu O. Genetic counselling in patients with bipolar disorder-ethical
challenges. 25th European Congress of Psychiatry. European Psychiatry
2017;41(Suppl.1):S329.
89. Vasiliu O, Vasile D, Vasiliu DG, Vasile F. Health-related quality of life in old
age institutionalized patients with neurocognitive disorders. 25th European Congress of
90. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Cognitive behavioral therapy in
internet addiction- A case series. 25th European Congress of Psychiatry. European
91. Vasile D, Vasiliu O, Fainarea AF, Patrascu MC, Morariu EA, Androne FT,
Vasiliu DG. Pharmacological management of antipsychotic-induced obesity- a systematic
literature review. 30th ECNP Congress. European Neuropsychopharmacology
2017;27(Suppl.4):S928-929.
92. Petrescu B, Vasile D, Vasiliu O, Mangalagiu A, Riga D, Riga S, Mitrache A,
Simioniuc-Petrescu A. Evaluation of trazodone and quetiapine in patients with Alzheimer’s
type dementia and sleep disturbance. 31st ECNP Congress. European
Neuropsychopharmacology 2018;29(Suppl.1):S156.
93. Vasiliu O. Internet use disorder in patients diagnosed with type I bipolar disorder-
a case series. The 21st Annual ISBD Conference: Global Advances in Bipolar Disorder and
Depression. Bipolar Disorders 2019;21(Suppl.1):90.
94. Vasiliu O, Vasile D. Personality disorders in patients with bipolar I and II
disorder. The 21st Annual ISBD Conference: Global Advances in Bipolar Disorder and
95. Vasiliu O. Treatment-emergent affective switch in bipolar type I disorder- a case
series. The 21st Annual ISBD Conference: Global Advances in Bipolar Disorder and
96. Vasiliu O. Analysis of substance use disorders comorbidity in patients diagnosed
with bipolar I and II disorder. The 21st Annual ISBD Conference: Global Advances in
Bipolar Disorder and Depression. Bipolar Disorders 2019;21(Suppl.1):89.
97. Vasiliu O. Behavioural addictions in patients diagnosed with bipolar disorders.
The 21st Annual ISBD Conference: Global Advances in Bipolar Disorder and Depression.
Bipolar Disorders 2019;21(Suppl.1):89.
98. Vasiliu O. Personality disorders diagnosed in patients with schizophrenia
spectrum disorders – a retrospective analysis. The 2019 Congress of the Schizophrenia
International Research Society. Schizophrenia Bulletin 2019;45(Suppl.2):S328.
99. Vasiliu O. Evaluation of suicide risk in schizophrenia spectrum disorders – a
literature review. The 2019 Congress of the Schizophrenia International Research Society.
Schizophrenia Bulletin 2019;45(Suppl.2):S276-277.
11
100. Vasiliu O. Naltrexone as maintenance treatment in opioid use disorder comorbid
with schizophrenia – a case series. The 2019 Congress of the Schizophrenia International
Research Society. Schizophrenia Bulletin 2019;45(Suppl.2):S247.
101. Vasiliu O. Improving therapeutic adherence in schizophrenia spectrum disorders-
from nursing approaches to new technologies. The 2019 Congress of the Schizophrenia
International Research Society. Schizophrenia Bulletin 2019;45(Suppl.2):S247-248.
102. Vasiliu O, Vasile D, Vasiliu DG, Vasile F. Therapeutic management of patients
diagnosd with schizophrenia and major neurocognitive disorder due to Alzheimer’s disease.
The 2019 Congress of the Schizophrenia International Research Society. Schizophrenia
Bulletin 2019;45(Suppl.2):S327-328.
103. Vasiliu O. Case management in buying disorder and borderline personality
disorder dual diagnosis. 6th International Conference on Behavioral Addictions. Journal of
Behavioral Addictions 2019;8(Suppl.1):164
104. Vasiliu O. Buying disorder- the history and the future of a nosological concept.
6th International Conference on Behavioral Addictions. Journal of Behavioral Addictions
2019;8(Suppl.1):164-165
105. Vasiliu O. Evaluation of buying disorder severity through validated instruments-
a review of current data. 6th International Conference on Behavioral Addictions. Journal of
Behavioral Addictions 2019;8(Suppl.1):166
106. Vasiliu O. Social media addiction- the dark side of post-modern technology. 6th
International Conference on Behavioral Addictions. Journal of Behavioral Addictions
2019;8(Suppl.1):174
107. Vasiliu O. The use of structured instruments for evaluating cell phone addiction
severity. 6th International Conference on Behavioral Addictions. Journal of Behavioral
Addictions 2019;8(Suppl.1):192-193
108. Vasiliu O. Treatment of schizophrenia in late life- clinical vignettes. 27th
109. Vasiliu O. Immunological agents for neurocognitive disorders- a review of the
current evidence. 27th European Congress of Psychiatry. European Psychiatry
2019;56(Suppl.1):S178.
110. Vasiliu O. Combined pharmacological treatment for alcohol use disorders-
review of current evidence. 27th European Congress of Psychiatry. European Psychiatry
2019;56(Suppl.1):S540.
111. Vasiliu O. Efficacy and tolerability of pharmacological agents for Internet
gaming disorder- a systematic literature review. 27th European Congress of Psychiatry.
European Psychiatry 2019;56(Suppl.1):S540-541.
112. Vasiliu O. Cognitive behavioral therapy in social anxiety disorder- a case series.
27th European Congress of Psychiatry. European Psychiatry 2019;56(Suppl.1):S329-330.
113. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Schizophrenia and opioid use
disorder dual diagnosis- a case series. 27th European Congress of Psychiatry. European
114. Vasile D, Vasiliu O. Substance use disorders comorbidity in a sample of patients
with panic disorder and agoraphobia. 27th European Congress of Psychiatry. European
115. Vasile D, Vasiliu O. Psychiatric evaluation for detection of major depression in
patients with multiple sclerosis. 27th European Congress of Psychiatry. European Psychiatry
2019;56(Suppl.1):S95.
116. Petrescu B, Vasile D, Vasiliu O, Mangalagiu A, Candea C, Riga D, Riga S,
Mitrache A. Management of psychosis with quetiapine in Alzheimer type dementia and
Parkinson type dementia. 32nd ECNP Congress. European Neuropsychopharmacology
2019 ;29(6) :S134-S135.
12
117. Vasiliu O. Transcranial magnetic stimulation in schizophrenia with prominent
negative symptoms- A review of the literature. Schizophrenia Bulletin
2020;46(Suppl.1):S113.
118. Vasiliu O. The use of novel psychoactive substances in the prodromal phase of
schizophrenia- A case series. Schizophrenia Bulletin 2020;46(Suppl.1):S210.
119. Vasiliu O. Changes in theory of mind detected in schizophrenia spectrum
disorders- A literature review. Schizophrenia Bulletin 2020;46(Suppl.1):S209-210.
120. Vasiliu O. Treatment strategies for ultra-resistant schizophrenias. Schizophrenia
Bulletin 2020;46(Suppl.1):S306-307.
121. Vasiliu O. Therapeutic management in multiple sclerosis and schizophrenia
spectrum disorders dual diagnosis. Schizophrenia Bulletin 2020;46(Suppl.1):S306.
122. Vasiliu O, Voicu VA. Gabapentinoids in the maintenance phase of bipolar type I
and II disorders- A case series. 22nd Annual Conference of the International Society for
Bipolar Disorders, S47. Bipolar Disorders 2020;22(Suppl.1):109.
123. Vasiliu O, Vasiliu D, Voicu VA, Vasile D. Evaluation of suicide risk in bipolar
disorders using structured instruments. 22nd Annual Conference of the International Society
for Bipolar Disorders, S81. Bipolar Disorders 2020;22(Suppl.1):122.
124. Vasile D, Vasiliu O, Vasiliu DG. Treatment perspectives based on translational
research in bipolar disorders. 22nd Annual Conference of the International Society for
Bipolar Disorders, S86. Bipolar Disorders 2020;22(Suppl.1):124.
125. Vasiliu O. Prognosis evaluation in patients with alcohol use disorder and bipolar
disorders dual diagnosis. 22nd Annual Conference of the International Society for Bipolar
Disorders, F29. Bipolar Disorders 2020;22(Suppl.1):70-71
126. Vasiliu O. Therapeutic management of cyclothymia- A literature review. 22nd
Annual Conference of the International Society for Bipolar Disorders, F50. Bipolar Disorders
2020;22(Suppl.1):78.
127. Vasile D, Vasiliu O. Therapeutic management of late-life bipolar depression- A
case series. 22nd Annual Conference of the International Society for Bipolar Disorders, F53.
Bipolar Disorders 2020;22(Suppl.1):79-80.
128. Vasiliu O. Therapeutic management of opioid use disorder in patients with
bipolar type I disorder. 22nd Annual Conference of the International Society for Bipolar
Disorders, F30. Bipolar Disorders 2020;22(Suppl.1):71.
Lucrări in-extenso indexate Thomson Reuters - Web of Science Core Collection

(ISI cu factor de impact, Emerging Sources Citation Index și ISI Proceedings)
1. Vasiliu O, Vasile D, Voicu V. Efficacy and tolerability of antibiotic augmentation
in schizophrenia spectrum disorders- A systematic literature review. Romanian Journal of
Military Medicine 2020;CXXIII(1):3-20.
2. Vasiliu O. Maintenance pharmacologic therapies for opioid use disorders: beyond
opioid agonists. Romanian Journal of Military Medicine 2019;CXXII(1):52-70.
3. Vasiliu O. Effects of the selective serotonin reuptake inhibitors over coagulation in
patients with depressive disorders- a systematic review and retrospective analysis. Romanian
Journal of Military Medicine 2019;CXXII(2):7-11.
4. Marinescu I, Vasiliu O, Vasile D. Translational approaches in treatment-resistant
depression based on animal model. Romanian Journal of Morphology and Embryology
2018;59(3):955-964. (ISI IF 2018=1.5)
5. Vasiliu O. Therapeutic management of schizophrenia and substance use disorders
dual diagnosis- clinical vignettes. Romanian Journal of Military Medicine 2018;CXXI(2):26-
34.
6. Vasiliu O, Vasile D, Făinărea AF, Pătrașcu MC, Morariu EA, Manolache R,
Alexandru I, Androne FT. Analysis of risk factors for antipsychotic-resistant schizophrenia in
young patients- a retrospective analysis. Romanian Journal of Military Medicine
2018;CXXI(1):25-29.
13
7. Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Tudor C, Ungureanu D,
Candea C. Efficacy and tolerability of calcium channel alpha-2-delta ligands in psychiatric
disorders. Romanian Journal of Military Medicine 2017;CXX(2):27-31.
8. Vasiliu O, Vasile D. Risk factors and quality of life in late-life depressive disorders.
Romanian Journal of Military Medicine 2016;CXIX(3):24-28.
9. Vasiliu O, Vasile D. Cultural and hystorical aspects of the psychoactive drugs
consumption. Romanian Journal of Military Medicine 2011;2(CXIV):33-39
10. Vasiliu O, Vasile D, Taină NF, Mangalagiu AG, Bănică A. Psychotropic
medication efficacy analysis in the the posttraumatic stress disorder related nightmares.
Romanian Journal of Military Medicine 2011;3(CXIV):31-38.
11. Vasile D, Vasiliu O. Dictionary of psychiatry - Anhedonia. Romanian Journal of
Military Medicine 2011;3(CXIV):24
12. Vasile D, Vasiliu O, Mangalagiu AG, Vasile ML, Grigorescu G, Vasile B, Terpan
M, Petrescu BM, Năstase DM. Defense mechanisms evaluation of the double diagnosis-
fibromyalgia and mixed anxiety-depressive disorder diagnosis. Romanian Journal of Military
Medicine 2010;2(CXIII):43-47
13. Vasile D, Vasiliu O, Mangalagiu AG, Nastase DM, Vasile B, Badescu E, Vasile
M, Terpan M. Psychopharmaceutical approach of the melatoninergic system in the sleep
disorders. Romanian Journal of Military Medicine 2010;1(CXIII):44-51
14. Vasile D, Vasiliu O. Dictionary of psychiatry- alogia. Romanian Journal of
Military Medicine 2010;4(CXIII):22
15. Vasile D, Vasiliu O, Mangalagiu AG, Ungureanu D, Vasile B, Vasile M, Nastase
DM. Psychopharmacological approaches in the secondary prevention of posttraumatic stress
disorder. Romanian Journal of Military Medicine 2010;4(CXIII):23-32
16. Vasile D, Vasiliu O. Management of affective symptoms and quality of life
improvement after primary brain tumor surgery. Proceedings of the World Medical
Conference, 2010, 276-278.
17. Vasile D, Vasiliu O. Anticonvulsants for severe behavioral disturbances in
Alzheimer dementia. Proceedings of the World Medical Conference, 2010, 279-283.
18. Vasile D, Vasiliu O. Management of cognitive symptoms in dementia associated
with Parkinson’s disease. Proceedings of the World Medical Conference, 2010, 284-286.
19. Vasile D, Vasiliu O. Matching psychotropics to neurobiological mechanisms in
the aftermath of a traumatic event: A literature review. Proceedings of the World Medical
Conference, 2010, 287-293.
20. Vasile D, Vasiliu O. Memory impairments in mental disorders. Romanian Journal
of Military Medicine 2009; 1:41-50
21. Vasile D, Vasiliu O. The role of the hypothalamo-hypophysis-adrenal axis in the
pathogenesis of anxiety disodrers. Romanian Journal of Military Medicine 2009; 2(CXII):35-
40
22. Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Stănescu B, Năstase DM.
Psychotic disorders due to psychotropic drugs. Romanian Journal of Military Medicine
2009;3(CXII):33-38
Lucrări prezentate la congrese și conferințe naționale și internaționale, publicate în

volume de rezumate, programul manifestărilor științifice respective sau în reviste de
specialitate indexate BDI
1. Vasiliu O, Vasile D, Gheorghe MD, Paraschiv S. The evaluation of personality
disorders in soldiers with self-injuring behavior. Proceedings of the 8th Congress of Balkan
Military Medical Committee Abstract Book 2003: 593
2. Vasiliu O, Vasile D, Gheorghe MD, Paraschiv S. Trazodone as an optimal
treatment for the sexual disfunctions in depressed patients. Proceedings of the 8th Congress of
Balkan Military Medical Committee Abstract Book 2003: 654
14
3. Vasile D, Vasiliu O, Gheorghe MD, Paraschiv S, Miclos M. Efficacy of the
mirtazapine treatment in the neoplasm associated pain. Proceedings of the 8th Congress of
4. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. Treatment of neoplasm secondary
depression using mirtazapine. Proceedings of the 8th Congress of Balkan Military Medical
Committee Abstract Book 2003: 658
5. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. The importance of the family
background in heroin-dependence primary and secondary prophylaxis. Proceedings of the 8th
Congress of Balkan Military Medical Committee Abstract Book 2003: 603
6. Vasile D, Vasiliu O. Weight gain as a secondary effect in typical and atypical
antipsychotic treatment of schizophrenia. Proceedings of the 8th Congress of Balkan Military
Medical Committee Abstract Book 2003: 67
7. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. Cardiovascular side effects
caused by the administration of atypical antipsychotics. Proceedings of the 8th Congress of
8. Paraschiv S, Vasile D, Gheorghe MD, Vasiliu O. The onset of action of
mirtazapine in a group of military personnell. Proceedings of the 8th Congress of Balkan
Military Medical Committee Abstract Book 2003: 101
9. Paraschiv S, Vasile D, Gheorghe MD, Vasiliu O. The efficacy of reboxetine in the
treatment of inhibited depression. Proceedings of the 8th Congress of Balkan Military
Medical Committee Abstract Book 2003: 588
10. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. Noncompliance factors in
schizophrenia treatment. Proceedings of the 9th Congress of BMMC. Abstract Book 2004;118
11. Vasiliu O, Vasile D, Gheorghe MD. The importance of self image distorsions in
depressive disorders with suicidal attempts. Proceedings of the 9th Congress of BMMC.
Abstract Book 2004;618
12. Vasile D, Vasiliu O, Gheorghe MD. Defense mechanisms in patients with
oncological pathology. Proceedings of the 9th Congress of BMMC. Abstract Book 2004;576
13. Vasile D, Vasiliu O, Gheorghe MD. Sleep quality improvement in depressed
patients receiving Trazodone. Proceedings of the 9th Congress of BMMC. Abstract Book
2004;455
14. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. Multiaxial diagnosis and quality
of life assessment in Alzheimer disease. Proceedings of the 9th Congress of BMMC. Abstract
Book 2004;371.
15. Vasile D, Gheorghe MD, Vasiliu O. Improvement of depressive symptomatology
in the onset of schizophrenia. Proceedings of the 9th Congress of BMMC. Abstract Book
2004;321
16. Vasile D, Gheorghe MD, Vasiliu O. Demographic data analysis in heroin
dependence patients. Proceedings of the 9th Congress of BMMC. Abstract Book 2004;233
17. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. Correlation between personality
features and adjustment disorders in conscripts. Proceedings of the 9th Congress of BMMC.
Abstract Book 2004;225
18. Vasiliu O. Depressive symptoms responsivity prophile in first episode of
schizophrenia. Interactive Educational Course for Young Psychiatrists and Researchers-
Poiana Brasov. Abstract book 2005:56-57
19. Vasile D, Gheorghe D, Vasiliu O. Trazodone in sexual dysfunctions of depressed
patients receiving selective serotonin reuptake inhibitors. Proceedings of the 12th WPA
International Congres. World Psychiatry 2004;3(Suppl.1):274
20. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. The effect of atypical
antipsychotics on depressive symptomatology in schizophrenia. Proceedings of the 17th
ECNP Congress. Final Program 2004: 108
15
21. Vasile D, Vasiliu O, Gheorghe MD. Atypical antipsychotics- Side effects profile.
Proceedings of the 1st International Congress of Biological Psychiatry. The World Journal of
Biological Psychiatry 2004;5(Suppl.1):7
22. Vasile D, Gheorghe M, Vasiliu O, Apetroaei A. Antidepresivele cu mecanism
dual versus SSRI in terapia tulburarilor depresive. Conferința Națională « Terapie şi
Management în Psihiatrie », Craiova, 2004
23. Vasile D, Gheorghe M, Apetroaei A, Vasiliu O. Implicaţiile neurobiologice şi
farmacoclinice ale efectului placebo. Conferința Națională « Terapie şi Management în
Psihiatrie », Craiova, 2004
24. Vasile D, Vasiliu O, Ojog D, Varzaru C. Combined therapy using cognitive
behavioural therapy and sertraline in recurrent major depressive disorder. Proceedings of the
10th Anniversary Congress of Balkan Military Medical Committee. Abstract Book 2005:401
25. Vasile D, Vasiliu O, Varzaru C, Vasile M. Cardiovascular diseases and
psychiatric disorders in elderly patients- a comorbidity evaluation study. Proceedings of the
10th Anniversary Congress of Balkan Military Medical Committee. Abstract Book 2005:402
26. Vasile D, Vasiliu O, Sarmache M, Varzaru C. Augmentation strategies for
Alzheimer Dementia: Memantine and Donepezil. Proceedings of the 10th Anniversary
Congress of Balkan Military Medical Committee. Abstract Book 2005:409
27. Vasile D, Vasiliu O, Vasile M, Sarmache M. Alcohol dependence and related
cognitive psychopathological syndromes. Proceedings of the 10th Anniversary Congress of
Balkan Military Medical Committee. Abstract Book 2005:408
28. Vasiliu O, Vasile D, Sarmache M, Varzaru C, Ivanov P, Vasile M, Ojog D.
Tardive Onset of Schizophrenia with Conversive Features- Case Presentation. Proceedings of
the 10th Anniversary Congress of Balkan Military Medical Committee. Abstract Book
2005:11
29. Vasile D, Vasiliu O, Ivanov P, Sarmache M, Varzaru C, Vasile M, Ojog D. The
use of Donepezil for Improving Cognitive Deficit in Alzheimer’s Disease. Proceedings of the
1st Students and Young Doctors European Congress of Military Medicine. Final Program
2005:11
30. Vasile D, Vasiliu O, Gheorghe MD. Comparative onset of antidepressant action in
parenteral vs. oral trazodone treatment. Proceedings of the 10th Anniversary Congress of
Balkan Military Medical Committee. Abstract Book 2005:13
31. Vasiliu O, Vasile D, Sarmache M, Vasile M. Evaluation of drug dependence
incidence in schizophrenic patients. Proceedings of the 10th Anniversary Congress of Balkan
Military Medical Committee. Abstract Book 2005:355
32. Vasile D, Vasiliu O, Varzaru C, Sarmache M. Tianeptine use in alcohol
dependence with associated depressive disorders. Proceedings of the 10th Anniversary
33. Vasile D, Vasiliu O, Ojog D, Vasile M. Ethiological considerations over the
personality change due to general medical conditions. Proceedings of the 10th Anniversary
34. Vasile D, Vasiliu O, Gheorghe MD. Atypical Antipsychotic Agents in Acute
Psychotic Disorder with Affective features. Proceedings of the 8th World Congress of
Biological Psychiatry. The World Journal of Biological Psychiatry 2005;6(Suppl.1):320
35. Vasile D, Vasiliu O. The effectiveness of Intravenous Trittico in Major
Depressive Episode. Proceedings of the 8th World Congress of Biological Psychiatry. The
World Journal of Biological Psychiatry 2005;6(Suppl.1):179
36. Vasile D, Vasiliu O, Apetroaei A, Paraschiv S, Gheorghe MD. Treatment in
Alzheimer Dementia with Depressed Mood. Proceedings of the 13th World Congress of
Psychiatry. Abstracts Book 2005:532
37. Vasile D, Vasiliu O, Vasile M, Ojog D. Depressive symptomatology cluster
analysis. Proceedings of the 11th Congress of Balkan Military Medical Committee. Abstract
Book 2006.
16
38. Vasiliu O, Vasile D, Ojog D, Varzaru C. Coping mechanisms as prognosis factors
in the cognitive behaviour therapy of major depressive disorder. Proceedings of the 11th
Congress of Balkan Military Medical Committee. Abstract Book 2006.
39. Vasiliu O, Vasile D, Varzaru C, Ojog D. Defense mechanisms analysis in
conscripts diagnosed with adjustment disorders. Proceedings of the 11th Congress of Balkan
Military Medical Committee. Abstract Book 2006.
40. Vasiliu O, Vasile D, Ivanov P, Paraschiv S. Psychotherapeutical crisis
interventions in depressive disorders with suicidal ideation. Proceedings of the 11th Congress
of Balkan Military Medical Committee. Abstract Book 2006.
41. Vasile D, Vasiliu O, Gheorghe MD, Vasile M. Aripiprazole efficacy in cronic
schizophrenia with prominent negative symptoms. Proceedings of the 11th Congress of
Balkan Military Medical Committee. Abstract Book 2006.
42. Vasiliu O, Ojog D. Compliance therapy in chronic schizophrenia. Centenarul
psihologiei la Universitatea Bucuresti, Conferinta Internationala, Bucuresti, 2006.
43. Vasiliu O, Vasile D, Sarmache M, Vasile M. Augmenting antidepressive
psychopharmachological approach with cognitive behavioural therapy in refractory major
depressive disorder. Proceedings of the 11th Congress of Balkan Military Medical Committee.
Abstract Book 2006.
44. Vasile D, Vasiliu O, Gheorghe MD, Ivanov P, Paraschiv S. Bupropion as craving
decreasing agent in alcohol dependent patients. Proceedings of the 11th Congress of Balkan
Military Medical Committee. Abstract Book 2006.
45. Vasile D, Vasiliu O, Ivanov P, Varzaru C, Ojog D, Paraschiv S. Comorbidity
association study in heroin dependent patients. 14th AEP Congress. European Psychiatry
2006;21(Suppl.1):S144
46. Vasile D, Vasiliu O, Ojog D, Sarmache M, Vasile M, Paraschiv S. Non-
benzodiazepine and benzodiazepine hypnotic comparative analysis in organic conditions
secondary insomnia. 14th AEP Congress. European Psychiatry 2006;21(Suppl.1):S152
47. Vasile D, Vasiliu O, Ivanov P, Paraschiv S. Effectiveness of cognitive behavioral
therapy in dual diagnosis: panic disorder and major depressive disorder. 14th AEP Congress.
European Psychiatry 2006;21(Suppl.1):S153
48. Ojog D, Vasiliu O. Let’s recognize the value of Stefan Odobleja. Centenarul
psihologiei la Universitatea Bucuresti, Conferinţa Internationala, Bucuresti, 2006.
49. Râmbu A, Marinescu G, Mititelu R, Ghita S, Mazilu C, Vasile D, Baloescu A,
Tudor C, Isacu S, Vasiliu O, Gheorghe MD, Codorean I. Prim episod schizofrenic – evaluare
SPECT cerebrală de perfuzie pre și post tratament cu antipsihotice atipice. Al II-lea Congres
Național de Medicină Nucleară, Bucureşti, 2006
50. Raceala A, Vasile D, Vasiliu O, Ivanov P, Dumitrache L. Scăderea toleranţei la
glucoză la pacienţii cu un prim episod de schizofrenie în tratament cu antipsihotice atipice. Al
13-lea Simpozion National de Psihoneuroendocrinologie, Cluj-Napoca, 2006
51. Paul I, Vasile D, Vasiliu O, Raceala A. Evaluarea creșterii nivelului de prolactină
la pacienții tratați cu antipsihotice atipice. Al 13-lea Simpozion Național de
Psihoneuroendocrinologie, Cluj-Napoca, 2006
52. Spiroiu C, Ranetti AE, Mazilu A, Mihai AM, Vasile D, Tudor C, Vasiliu O.
Hipotiroidism debutat ca psihoză -mixedema madness- prezentare de caz. Al 13-lea
Simpozion Național de Psihoneuroendocrinologie, Cluj-Napoca, 2006
53. Vasile D, Vasiliu O, Sarmache M, Vasile M. Managementul farmacoterapeutic al
pacienților psihotici agresivi. Conferinţa Naţională „Terapie și management în psihiatrie”,
Craiova, 2006
54. Vasiliu O, Vasile D, Ojog D. Comorbidităţi addictive în tulburarea de panică.
Conferinţa Naţională „Terapie şi management în psihiatrie”, Craiova, 2006
55. Vasile D, Vasiliu O, Varzaru C, Ivanov P. Evaluarea calității vietii la pacienții cu
demenţa vasculară. Conferinţa Naţională „Terapie şi management în psihiatrie”, Craiova,
2006
17
56. Ojog D, Vasiliu O. Psychotherapy approaches in panic disorder and alcohol abuse
dual diagnosis. Centenarul Psihologiei la Universitatea Bucuresti, Conferinta Internationala,
Bucuresti, 2006
57. Ojog D, Vasiliu O. Corelarea depersonalizării cu trăsăturile de personalitate în
tulburările depresive. Conferinţa Naţională de Psihologie, Cluj-Napoca, 2006
58. Vasiliu O, Ojog D. Adaptarea tehnicilor terapeutice la stadiile schimbarii în
dependența de alcool. Conferinţa Naţională de Psihologie, Cluj-Napoca, 2006
59. Vasiliu O, Ojog D. Evaluarea comorbidității tulburare de personalitate-dependenţă
de substanţă. Conferinţa Naţională de Psihologie, Cluj-Napoca, 2006
60. Ojog D, Vasiliu O. Analiza factorilor schimbării terapeutice în tulburarea de
personalitate de tip borderline. Conferinţa Natională de Psihologie, Cluj-Napoca, 2006
61. Vasile D, Vasiliu O. New methods for mood disorders treatment. Proceedings of
th
the 12 Congress of Balkan Military Medical Committee. Abstract Book 2007:80.
62. Vasile D, Vasiliu O, Paraschiv S, Terpan M. Compliance therapy as increasing
adherence method for alcohol addiction. Proceedings of the 12th Congress of Balkan Military
Medical Committee. Abstract Book 2007:192.
63. Vasile D, Vasiliu O, Vasile M, Sarmache M. Ethiological considerations over
delirium due to general medical conditions. Proceedings of the 12th Congress of Balkan
Military Medical Committee. Abstract Book 2007:202.
64. Vasile D, Vasiliu O, Paraschiv S, Terpan M. Comparative analysis of second
generation antipsychotics in the treatment of negative symptoms in chronic schizophrenia.
Proceedings of the 12th Congress of Balkan Military Medical Committee. Abstract Book
2007:207.
65. Vasile D, Vasiliu O, Paraschiv S, Brisculescu R. Combined valproate and atypical
antipsychotics in the treatment of manic episodes. Proceedings of the 12th Congress of
Balkan Military Medical Committee. Abstract Book 2007:208.
66. Vasiliu O, Vasile D, Vasile M, Sarmache M. Cognitive behavioural therapy in
generalized anxiety disorder. Proceedings of the 12th Congress of Balkan Military Medical
Committee. Abstract Book 2007:209.
67. Vasile D, Vasiliu O, Ojog D, Terpan M. Bupropion administration in major
depression with alcohol dependence dual diagnosis. Proceedings of the 12th Congress of
Balkan Military Medical Committee. Abstract Book 2007:211.
68. Vasiliu O, Vasile D, Brisculescu R, Ojog D. Defense mechanisms analysis in
somatoform disorders. Proceedings of the 12th Congress of Balkan Military Medical
Committee. Abstract Book 2007:208
69. Vasile D, Vasiliu O, Sarmache M, Vasile M. Aripiprazole administration in
schizoaffective disorder, bipolar type. Proceedings of the 12th Congress of Balkan Military
Medical Committee. Abstract Book 2007:214.
70. Vasiliu O, Vasile D, Brisculescu R, Ojog D. Anxiety disorder screening in general
internal medicine clinic hospitalised patients Proceedings of the 12th Congress of Balkan
Military Medical Committee. Abstract Book 2007:215.
71. Spiroiu C, Ranetti AE, Mazilu A, Mihai AM, Vasile D, Tudor C, Vasiliu O.
Hypothyroidism presenting as psychosis: mixedema madness case report. Proceedings of the
12th Congress of Balkan Military Medical Committee. Abstract Book 2007:198.
72. Ivanov P, Răceală A, Vasiliu O, Paun D. L-thyroid hormone enhancement of
antidepresant treatment in major depressive episode. Proceedings of the 9th European
Congress of Endocrinology Endocrine Abstracts 2007;14:P522.
73. Răceală A, Ivanov P, Vasiliu O, Paun D. Neuropsychiatric manifestations in
patients with primary hyperparathyroidism and outcome following surgery. Proceedings of
the 9th European Congress of Endocrinology Endocrine Abstracts 2007;14:P442.
74. Vasile D, Vasiliu O. Psychiatric comorbidity in somatoform disorders.
Proceedings of the 13th Congress of Balkan Military Medical Committee, Kusadasi, 2008
18
75. Vasile D, Vasiliu O, Vasile M, Terpan M, Ojog D. Prevalence of delirium and its
influence over the prognosis in patients diagnosed with dementia. Proceedings of the 13th
Congress of Balkan Military Medical Committee, Kusadasi, 2008
76. Vasile D, Vasiliu O, Cretu O, Patriche D, Stanescu B, Bancescu R. Dual diagnosis
in alcohol dependence. Proceedings of the 13th Congress of Balkan Military Medical
Committee, Kusadasi, 2008
77. Vasile D, Vasiliu O, Vasile M, Cretu O, Terpan M. Crisis therapy intervention in
panic disorder. Abstracts of the XIVth World Congress of Psychiatry. Journal of Czech and
Slovak Psychiatry 2008;104 (Suppl.2):1235
78. Vasile D, Vasiliu O, Patriche D, Ivanov P, Stănescu B. Cognitive-behavioural
therapy and antidepressant drug treatment in irritable bowel syndrome. Abstracts of the XIVth
World Congress of Psychiatry. Journal of Czech and Slovak Psychiatry 2008;104
(Suppl.2):933
79. Vasile D, Vasiliu O, Vasile M, Patriche D, Ojog D. The Influence of coping
mechanisms over the evolution of acute stress disorder. Abstracts of the XIVth World
Congress of Psychiatry. Journal of Czech and Slovak Psychiatry 2008;104 (Suppl.2):1145
80. Vasile D, Vasiliu O, Vasile M, Terpan M, Ojog D. Guided imagery applications in
breast cancer related mixed anxious-depressive disorder. Abstracts of the XIVth World
Congress of Psychiatry. Journal of Czech and Slovak Psychiatry 2008;104 (Suppl.2):1461
81. Vasile D, Vasiliu O, Creţu O, Ivanov P, Stănescu B. The management of
alcoholism of alcohol dependence in patients with oncologic disease. Abstracts of the XIVth
World Congress of Psychiatry. Journal of Czech and Slovak Psychiatry 2008; 104
(Suppl.2):1461
82. Vasiliu O, Micloş M, Vasile D, Ivanov P, Cretu O. Amisulpride efficacy in the
management of psychosis in elderly patients. Proceedings of the 21st ECNP Congress. Final
Program 2008.
83. Vasiliu O, Vasile D. Intramuscular ziprasidone efficacy in the acute treatment of
bipolar disorder mixed episode. Proceedings of the 21st ECNP Congress. Final Program
2008.
84. Staicu M, Vasiliu O, Ojog D, Patriche D, Grigorescu G. The evaluation of coping
strategies in posttraumatic stress disorder. The 5th World Congress for Psychotherapy,
Beijing, 2008.
85. Ojog D, Vasiliu O. Reducerea impactului negativ asupra apartinatorilor a
simptomelor comportamentale și cognitive ale persoanelor cu boala Alzheimer. Conferinţa
Natională de Psihologie, Timişoara, 2008
86. Ojog D, Vasiliu O. Dublul diagnostic tulburare de personalitate și tulburare
afectivă bipolară - implicații terapeutice. Conferinţa Natională de Psihologie, Timişoara,
2008
87. Vasiliu O, Ojog D. Relația mecanismelor defensive cu etapele schimbării
terapeutice în dependența de substanţă. Conferinţa Naţională de Psihologie, Timişoara, 2008
88. Vasiliu O, Ojog D. Rolul impactului motivational in rezolvarea ambivalentei la
persoanele cu tulburari adictive. Conferinţa Naţională de Psihologie, Timişoara, 2008
89. Vasiliu D, Grigorescu G, Tudor C, Vasiliu O, Grigorescu R. Efficacy of
aripiprazole vs. quetiapine for the treatment of hostility in acute patients with schizophrenia.
Proceedings of the 9th World Congress of Biological Psychiatry. The World Journal of
Biological Psychiatry 2009;10(Suppl.1):282
90. Vasile D, Vasiliu O, Vasile M, Grigorescu G, Terpan M. Duloxetine versus
escitalopram in the treatment of major depressive disorder and generalised anxiety disorder
dual diagnosis. Proceedings of the 9th World Congress of Biological Psychiatry. The World
Journal of Biological Psychiatry 2009;10(Suppl.1):384
91. Vasile D, Vasiliu O. Milnacipran efficacy in major depressive disorder and
alcohol dependence dual diagnosis. Proceedings of the 9th World Congress of Biological
Psychiatry. The World Journal of Biological Psychiatry 2009;10(Suppl.1):384
19
92. Vasile D, Vasiliu O, Mangalagiu AG, Bogdan V, Stanescu B, Banica A, Taina
NF. Multiaxial diagnosis in patients with combat related physical trauma- a case series. 16th
93. Vasile D, Vasiliu O, Mangalagiu AG. Quality of life assessment in patients
diagnosed with bipolar disorder and alcohol dependence. 11th International Review of Bipolar
Disorders. International Clinical Psychopharmacology 2011;26:e29.
94. Vasile D, Vasiliu O, Ojog GD. Quetiapine efficacy and tolerability in bipolar II
disorder with comorbid cluster C personality disorder. 11th International Review of Bipolar
Disorders. International Clinical Psychopharmacology 2011;26:e29.
95. Vasile D, Vasiliu O, Mangalagiu AG. Familial history of psychotic disorders in
patients with bipolar I and II disorder. 11th International Review of Bipolar Disorders.
International Clinical Psychopharmacology 2011;26:e29-30.
96. Vasile D, Vasiliu O, Ojog DG. Psychoactive substance induced manic episodes in
a population of young patients- a case series. 11th International Review of Bipolar Disorders.
International Clinical Psychopharmacology 2011;26:e30.
97. Taina NF, Vasile D, Vasiliu O, Mangalagiu AG, Stanescu B. 25 years of
fluoxetine: how far are we from an optimal treatment for depression? Therapeutics,
Pharmacology and Clinical Toxicology 2011;XV(Suppl.II):74
98. Taina NF, Vasile D, Vasiliu O, Mangalagiu AG, Banica A, Ojog DG. Nightmare
pharmacologic treatment in posttraumatic stress disorder- a systematic literature review.
Therapeutics, Pharmacology and Clinical Toxicology 2011;XV(Suppl.II):74
99. Vasile D, Vasiliu O, Ungureanu D, Tudor C, Bogdan V, Mangalagiu AG, Banica
A, Grosu G, Meliaca A. Analiza eficacității terapeutice a duloxetinei comparativ cu
inhibitorii selectivi ai recaptării serotoninei în depresia majoră recurentă cu manifestări
atipice. Zilele SUUMC Dr.Carol Davila, Bucureşti, 2011
100. Vasile D, Vasiliu O, Mangalagiu AG, Taină NF, Bănică A, Blându M, Ojog DG.
Aspecte etice în domeniul consilierii genetice în cazul pacienţilor diagnosticaţi cu
schizofrenie. A VII-a Conferinţă Naţională de Bioetică, Bucureşti, 2011
101. Vasiliu O, Vasile D, Mangalagiu AG, Taină NF, Bănică A, Blându M, Ojog DG.
Provocări etice în psihooncologie. A VII-a Conferinţă Naţională de Bioetică, Bucureşti, 2011
102. Vasiliu O, Vasile D, Mangalagiu AG, Taină NF, Bănică A, Blându M, Ojog DG.
Aspecte etice ale consimţământului informat în cazul pacienţilor cu boala Alzheimer. A VII-a
Conferinţă Naţională de Bioetică, Bucureşti, 2011
103. Vasile D, Vasiliu O, Ungureanu D, Tudor C, Bogdan V, Mangalagiu AG, Banica
A, Grosu G, Meliaca A. Analiza eficacității terapeutice a duloxetinei comparativ cu
inhibitorii selectivi ai recaptării serotoninei în depresia majoră recurentă cu manifestări
atipice. Revista de Medicina Militara 2011;CXIV(Suppl):24
104. Taina NF, Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Ojog DG.
Effectiveness of naltrexone administration in alcohol dependence with comorbid axis II
diagnosis. 13th International Congress of the Romanian Society of Pharmacology,
Therapeutics and Clinical Toxicology, 2012. Abstract Book p.98
105. Vasile D, Vasiliu O, Taina NF, Mangalagiu AG, Petrescu B, Blandu M, Ojog
DG. Quality of life assessment in colon malignant tumors asssociated depression during
trazodone treatment. 13th International Congress of the Romanian Society of Pharmacology,
Therapeutics and Clinical Toxicology, 2012. Abstract Book p.12
106. Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Ungureanu D, Petrescu BM,
Bogdan V, Grigorescu G, Blandu M. Diagnosticul multiaxial în tulburările somatoforme.
Zilele Spitalului Universitar de Urgență Militar Central „Dr.Carol Davila”, 2012, Volum de
rezumate
107. Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Petrescu BM. Newly diagnosed
Alzheimer Dementia cases in non-psychiatric departments of a general medical hospital- a
liaison psychiatry study. Romanian Journal of Psychiatry 2013;XV(Suppl.1):P-69
20
108. Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Blandu M. Analysis of the
organic comorbidities in early-onset Alzheimer Dementia patients. Romanian Journal of
Psychiatry 2013;XV(Suppl.1):OC-01
109. Tudor C, Vasiliu O, Zavoianu M, Grigorescu G, Mangalagiu AG, Vasile D,
Magazin O. The Efficacy of dual action antidepressants in depressive disorder associated
with systematic lupus erythematosus. Romanian Journal of Psychiatry 2013;XV (Suppl.1):P-
51
110. Vasile D, Vasiliu O, Mangalagiu AG, Sopterean G, Bratu R. Galantamine
efficacy and tolerability in amnestic mild cognitive impairment. P-07-021. 11th World
Congress of Biological Psychiatry 2013
111. Vasile D, Vasiliu O, Taina NF, Bratu R, Sopterean G. Comparative analysis of
duloxetine and SSRIs in oncologic patients with major depressive disorder. P-10-022. 11th
World Congress of Biological Psychiatry 2013
112. Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Taina NF. Combined
naltrexone and cognitive therapy in binge drinking patients with cluster B personality
features. P-17-014. 11th World Congress of Biological Psychiatry 2013
113. Vasile D, Vasiliu O, Mangalagiu AG, Sopterean G, Bratu R, Ojog DG.
Agomelatine versus escitalopram in the treatment of elderly patients with post-stroke
depression. P-21-016. 11th World Congress of Biological Psychiatry 2013
114. Vasile D, Vasiliu O, Petrescu MB. Efficacy of rivastigmine patch in mixed
severe neurocognitive disorders. Zilele Spitalului Universitar de Urgență Militar Central
“Dr. Carol Davila”, 2014, Programul final
115. Vasile D, Vasiliu O. Metabolic profile of long-acting injectable risperidone
versus olanzapine pamoate in chronic schizophrenia. P-24-003. 11th World Congress of
Biological Psychiatry 2013
116. Vasile D, Vasiliu O, Vasiliu DG, Sopterean GA, Bratu RE, Androne F, Vasile F.
Efficacy and tolerability of venlafaxine switch in serotonin selective reuptake inhibitors
treated patients with partial response. P-22. Abstracts of the 12th World Congress of
Biological Psychiatry 2015.
117. Vasile D, Vasiliu O, Vasiliu DG, Androne F, Vasile F. Comparative efficacy of
bupropion and duloxetine in depressive disorder due to Parkinson’s disease. P-15. Abstracts
of the 12th World Congress of Biological Psychiatry 2015.
118. Petrescu B, Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Ungureanu D. A
comparative prospective study of agomelatine versus escitalopram in treatment of severe
major depressive disorder. P.2.f.009. Abstracts of the 28th ECNP 2015. European
119. Vasile D, Petrescu BM, Vasiliu O, Mangalagiu A, Candea C. Delirium and
depression: relationship and clinical overlap in elderly people. Abstracts of 20th Congress of
Balkan Military Medical Committee. Balkan Military Medical Review 2015;18(5):e77.
120. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Quality of life assessment in
schizophrenia diagnosed patients with predominant negative symptoms. T273. Final
Programme. 5th Schizophrenia Research Society Conference 2016.
121. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Pharmacologic management in cases
of dual diagnosis- schizophrenia and alcohol use disorder. M108. Final Programme. 5th
Schizophrenia Research Society Conference 2016.
122. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Aggressivity management in
schizophrenia diagnosed patients using calcium channel alpha2-delta ligands. S50. Final
Programme. 5th Schizophrenia Research Society Conference 2016.
123. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Assessment of suicide risk in
schizophrenia with addictive comorbidity. EW567. Abstracts of the 24th European Congress
of Psychiatry. European Psychiatry 2016;33: S315.
21
124. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Assessment of sexual dysfunctions in
depressive disorder. EV548. Abstracts of the 24th European Congress of Psychiatry.
European Psychiatry 2016;33: S525.
125. Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Tudor C, Candea C, Bazac-
Bratu RE, Androne FT, Alboaie AF, Patrascu M, Patrascu EA. Improving treatment
adherence in schizophrenia diagnosed patients by using long acting injectable antipsychotics.
Carol Davila University Central Emergency Military Hospital Scientific Days, 6th Ed.
Romanian Journal of Military Medicine 2016; vol.CXIX(Suppl.):5
126. Nistor A, Hara T, King C, Blebea F, Iftodi A, Tudor C, Vasiliu O, Vasile D.
Primary prevention in unipolar depression. Carol Davila University Central Emergency
Military Hospital Scientific Days, 6th Ed. Romanian Journal of Military Medicine 2016;
vol.CXIX(Suppl.):7
127. Candea C, Vasile D, Vasiliu O, Petrescu B, Mangalagiu A, Candea I, Badic AM.
Psychiatry and terrorism. Carol Davila University Central Emergency Military Hospital
Scientific Days, 6th Ed. Romanian Journal of Military Medicine 2016; vol.CXIX(Suppl.):30
128. Candea C, Vasile D, Vasiliu O, Petrescu B, Mangalagiu A, Candea I, Badic AM.
Transcultural psychiatry. Carol Davila University Central Emergency Military Hospital
Scientific Days, 6th Ed. Romanian Journal of Military Medicine 2016; vol.CXIX(Suppl.):30
129. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Assessment of eating disorders in
patients diagnosed with major depressive disorder. EV398. Abstracts of the 24th European
Congress of Psychiatry. European Psychiatry 2016;33: S475.
130. Vasile D, Vasiliu O, Petrescu MB. Efficacy of rivastigmine patch in mixed
severe neurocognitive disorders. Zilele Spitalului Universitar de Urgență Militar Central
“Dr. Carol Davila”, 2014, Programul final
131. Vasiliu O. Reintegration of schizophrenia diagnosed patients in social
environment through art-therapy- a pilot study. Proceedings of the 8th LUMEN International
Scientific Conference, 2017;931-942.
132. Vasiliu O. Improving quality of life in caregivers of Alzheimer dementia
patients- a tepwise approach. Proceedings of the 8th LUMEN International Scientific
Conference, 2017;943-958.
133. Vasiliu O. Ways to decrease social stigma in schizophrenia- toward a social
policy project. Abstracts of the 8th LUMEN International Scientific Conference, 2017;344
134. Vasiliu O. Social factors for major depressive disorder negative prognosis in
young patients. Proceedings of the 8th LUMEN International Scientific Conference,
2017;959-967
135. Vasiliu O. Quality of life evaluation in patients diagnosed with alcohol
dependence and major depressive disorder dual diagnosis. 14th World Federation of Societies
of Biological Psychiatry Congress, June 2017, Scientific Programme
136. Vasile D, Vasiliu O. Quality of life evaluation in oncologic patients with
adjustment disorder. 14th World Federation of Societies of Biological Psychiatry Congress,
June 2017, Scientific Programme
137. Petrescu BM, Vasile D, Vasiliu O, Mangalagiu A, Candea C. Borderline
personality disorder- a challenging diagnosis. 22nd Congress of the Balkan Military Medical
Committee, 2017; OP30.
138. Badic M, Vasile D, Vasiliu O, Petrescu BM, Candea CA. Is there a different
prevalence of depression among the military and the general active population? 22nd
Congress of the Balkan Military Medical Committee, 2017; OP157.
139. Petrescu BM, Mitrache A, Vasile D, Vasiliu O, Mangalagiu AG, Candea CA.
Prescribing anticholinergic drugs in neurocognitive disorders: pharmacological implications
and clinical evidence. Abstracts of the 1st Eastern European Conference of Mental Health.
American Journal of Psychiatry and Neuroscience 2017;5(6-1):14
140. Petrescu BM, Vasile D, Vasiliu O, Mangalagiu AG, Badic MA. The
psychophysiological effects of chemical terrorist attacks- the sarin neurotoxic agent.
22
Abstracts of the 1st Eastern European Conference of Mental Health. American Journal of
Psychiatry and Neuroscience 2017;5(6-1):15
141. Vasile D, Vasiliu O, Petrescu BM, Badic AM, Mangalagiu AG, Tudor C, Candea
CA. New pharmacological approaches in obesity. The 10th National Conference of
Biological Psychiatry and Psychopharmacology. Romanian Journal of Psychopharmacology
2017;17(1):O06
142. Vasile D, Vasiliu O, Badic AM, Petrescu BM, Candea CA, Tudor C, Mangalagiu
AG. Quality of life assessment during pharmacological treatment in patients with
schizophrenia. The 10th National Conference of Biological Psychiatry and
Psychopharmacology. Romanian Journal of Psychopharmacology 2017;17(1):O15
143. Vasile D, Vasiliu O, Petrescu BM, Candea CA, Androne F, Fainarea AF,
Patrascu M, Morariu EA. Recommendations for long acting injectable antipsychotics in
patients with schizophrenia. The 10th National Conference of Biological Psychiatry and
144. Vasiliu O, Vasile D, Badic A, Petrescu BM, Candea CA. Personalized medicine
and psychopharmacogenomics. The 10th National Conference of Biological Psychiatry and
145. Vasiliu O, Vasile D, Petrescu BM, Badic A, Candea CA. Augmenting selective
serotonin reuptake inhibitors in case of partial response in patients with major depressive
disorder. The 10th National Conference of Biological Psychiatry and Psychopharmacology.
Romanian Journal of Psychopharmacology 2017;17(1):O22
146. Fainarea AF, Patrascu MC, Morariu EA, Vasiliu O, Vasiliu DG, Vasile D. Vagus
nerve stimulation in Alzheimer Dementia and in patients with risk for developing
neurocognitive disorders- A literature review. WPA Thematic Congress, 2018:EP07.
147. Morariu EA, Patrascu MC, Fainarea AF, Vasiliu O, Vasile D. The gut microbiota
modification as a therapeutic strategy for psychiatric disorders- A review of the available
data. WPA Thematic Congress, 2018:SC17.
148. Patrascu MC, Morariu EA, Fainarea AF, Vasiliu O, Vasile D. Project for an
Internet-based anti-stigmatization platform dedicated to patients diagnosed with
schizophrenia. WPA Thematic Congress, 2018:SC24.
149. Vasile D, Vasiliu O. A randomized, open-label trial to evaluate pharmacogenetic
mediators in treatment-resistant depression. WPA Thematic Congress, 2018;EP10.
150. Vasiliu O. Defining new atypical antipsychotics- What’s really new about them?
WPA Thematic Congress, 2018:SC03.
151. Vasiliu O. Deep brain stimulation for Tourette syndrome: A review of current
evidence. WPA Thematic Congress, 2018:SC11.
152. Vasile D, Vasiliu O. Internet-based cognitive-behavioral therapy for patients
diagnosed with pathological online gambling disorder. WPA Thematic Congress, 2018:SC13
153. Vasiliu O. Pharmacogenomic-based approach in treatment-resistant
schizophrenia. WPA Thematic Congress, 2018:SC15.
154. Vasiliu O. Opioid antagonists efficacy and tolerability in young patients
diagnosed with gambling disorder- A case series. 26th European Congress of Psychiatry.
European Psychiatry 2018;48(e-Suppl.1):S234.
155. Vasile D, Vasiliu O, Fainarea AF, Patrascu MC, Morariu EA, Manolache R,
Alexandru I. Algorithm for evaluation of the quality of life in caregivers of patients
diagnosed with Alzheimer neurocognitive disorder. 26th European Congress of Psychiatry.
European Psychiatry 2018;48(e-Suppl.1):S205.
156. Vasiliu O. Genetic polymorphism of CYP2C19 and clinical response to
antidepressants- A literature review. 26th European Congress of Psychiatry. European
Psychiatry 2018;48(e-Suppl.1):S178.
157. Vasiliu O. Domains of stigmatization and reported causal factors for
discrimination in schizophrenia- A survey of patients and their caregivers. 26th European
Congress of Psychiatry. European Psychiatry 2018;48(e-Suppl.1):S228.
23
158. Vasiliu O. Analysis of psychiatric comorbidities in type I diabetes mellitus and
step-wise diagnosis approach proposal. 26th European Congress of Psychiatry. European
Psychiatry 2018;48(e-Suppl.1):S518.
159. Vasiliu O. Recommendations for the cognitive-behavioral therapy in
technological addictions. 26th European Congress of Psychiatry. European Psychiatry
2018;48(e-Suppl.1):S743.
160. Vasile D, Vasiliu O. Current stage of the biological therapies for cocaine
dependence- A narrative review. 26th European Congress of Psychiatry. European Psychiatry
2018;48(e-Suppl.1):S233.
161. Vasiliu O. Enfoque farmacológico en trastornos combinados por el uso de drogas
y adicciones conductuales. World Psychiatric Association 18th World Congress of
Psychiatry. Final Programme WCP18-0113, Mexic, 2018.
162. Vasiliu O. Alpha2-delta ligands for alcohol use disorder- A study project. World
Psychiatric Association 18th World Congress of Psychiatry. Final Programme WCP18-0009,
Mexic, 2018.
163. Vasiliu O. Trastornos del sueño inducidos por los inhibidores selectivos de la
recaptacíon de serotonina: Una revisión narrativa. World Psychiatric Association 18th World
Congress of Psychiatry. Final Programme WCP18-0112, Mexic, 2018.
164. Vasiliu O. Psychotherapy for compulsive buying disorder- A review of evidence
and staged approach. World Psychiatric Association 18th World Congress of Psychiatry.
Final Programme WCP18-0008, Mexic, 2018.
165. Vasiliu O. Una revisión de las terapias disponibles para los trastornos de la
alimentación. World Psychiatric Association 18th World Congress of Psychiatry. Final
Programme WCP18-0116, Mexic, 2018.
166. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Pharmacological management of
Internet gaming disorder- a systematic literature review. EP.1001. 31st ECNP Congress,
2018. Final Programme:113.
167. Vasiliu O, Vasile D, Mangalagiu AG, Petrescu MB, Candea CA, Tudor C,
Fainarea AF, Patrascu MC, Morariu EA, Badic AM, Manolache RE, Alexandru IA.
Pharmacological management of late-onset schizophrenia- a case series. EP.1002. 31st ECNP
Congress, 2018. Final Programme:113.
168. Vasiliu O, Vasile D, Petrescu MB, Mangalagiu AG, Candea CA, Fainarea AF,
Patrascu MC, Morariu EA, Badic AM, Manolache RE, Alexandru IA. Combined
pharmacological treatment for alcohol dependence- review of current evidence and new study
project. EP1003.31st ECNP Congress, 2018. Final Programme:113.
169. Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Tudor C, Candea CA,
Ungureanu D. Biological therapies for Alzheimer Dementia- the current status of clinical
research and future trends. EP1000. 31st ECNP Congress, 2018. Final Programme:113.
170. Vasiliu O. Methods for evaluation of the quality of life during pharmacological
treatment in young adults diagnosed with schizophrenia. A XI-a Conferință Națională de
Psihiatrie Biologică și Psihofarmacologie. Romanian Journal of Psychiatry 2018;XX(1):1
171. Vasiliu O, Vasile D, Alboae AF, Patrascu MC, Morariu EA, Manolache R,
Alexandru I, Badic AM. New therapeutical means for schizophrenia- focus on the deep brain
stimulation. A XI-a Conferință Națională de Psihiatrie Biologică și Psihofarmacologie.
Romanian Journal of Psychiatry 2018;XX(1):5
172. Vasiliu O. Augmenting antipsychotic treatment with psychotherapy for the
negative symptoms of schizophrenia- A narrative review. A XI-a Conferință Națională de
Psihiatrie Biologică și Psihofarmacologie. Romanian Journal of Psychiatry 2018;XX(1):10
173. Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Candea C, Tudor C,
Ungureanu D. Analysis of organic and psychiatric comorbidities in patients with
schizophrenia during antipsychotic treatment. A XI-a Conferință Națională de Psihiatrie
Biologică și Psihofarmacologie. Romanian Journal of Psychiatry 2018;XX(1):15
24
174. Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Candea CA, Tudor C,
Ungureanu D, Miclos M, Draghici A, Florescu C. Anti-inflammatory interventions in major
depressive disorder: status of research and therapeutic perspectives. Carol Davila University
Central Emergency Military Hospital Scientific Days, 9th Ed., Romanian Journal of Military
Medicine 2019;CXXII (Suppl.1):10.
175. Vasiliu O, Vasile D, Morariu EA, Stanescu RDA, Fainarea AF, Patrascu MC,
Manolache RE, Manolache IA, Ghenoiu IE, R.A.Lecu, Gionea MI, Gainaru F, Amanolesei I,
Vlaicu RG. New pharmacological approaches for binge-eating disorder. Carol Davila
University Central Emergency Military Hospital Scientific Days, 9th Ed., Romanian Journal
of Military Medicine 2019;CXXII (Suppl.1):15-16.
176. Vasiliu DG, Vasiliu O. Trastornos de la personalidad en un grupo de pacientes
diagnosticado de trastorno por uso de alcohol. 3rd WADD World Congress & 6th SEPD
International Congress, Madrid, 2019, Abstracts book, 123.
177. Vasiliu O. Tratamiento farmacológico de pacientes con trastorno bipolar y juego
patológico- una serie de casos. 3rd WADD World Congress & 6th SEPD International
Congress, Madrid, 2019, Abstracts book, 251.
178. Vasiliu O, Sirbu CA, Dobrescu L, Vasile D. Therapeutic management in cases of
Internet addiction disorder and alcohol use disorder dual diagnosis. 23rd World Congress of
Social Psychiatry, Bucharest, 2019, Abstract book 212.
179. Vasiliu O, Vasile D, Sirbu CA, Dobrescu L. Internet gaming disorder in elderly
patients- a case series. 23rd World Congress of Social Psychiatry, Bucharest, 2019, Abstract
book 212-213.
180. Vasiliu O, Sirbu CA, Dobrescu L, Vasile D, Morariu EA, Stanescu R,
Manolache RE, Alexandru IA, Ghenoiu I, Lecu RA, Gionea IM. Current status of a
postmodernist pathology- online shopping disorder. 23rd World Congress of Social
Psychiatry, Bucharest, 2019, Abstract book 211-212.
181. Vasiliu O, Sirbu CA, Dobrescu L, Vasile D, Mangalagiu AG, Petrescu BM,
Tudor C, Candea C, Ungureanu D, Miclos M, Draghici A, Florescu C. Advances in defining
social network site addiction. 23rd World Congress of Social Psychiatry, Bucharest, 2019,
Abstract book 213.
182. Vasiliu O. Therapeutic management of Internet sex addiction and schizophrenia
dual diagnosis. 23rd World Congress of Social Psychiatry, Bucharest, 2019, Abstract book
213-214.
183. Vasiliu O. Evaluation of mental status and co-morbidity in patients with Internet
addiction. American Psychological Association 2019 Convention, Final Programme, G-7,
177.
184. Vasiliu O, Vasiliu DG. Early maladaptive schemas and impulsity in binge eating
disorder with opioid use- a case series. American Psychological Association 2019
Convention, Final Programme, G-8, 177.
185. Vasiliu O, Voicu VA, Vasile D. Cannabis and eating disorders- a literature
review. The 4th International Medical Cannabis Conference. Med Cannabis and
Cannabinoids 2019;2:98.
186. Vasiliu O, Voicu VA, Vasile D. Health-related quality of life in cannabis use
disorder. The 4th International Medical Cannabis Conference. Med Cannabis and
187. Vasiliu O, Vasile D, Voicu VA. Schizophrenia and cannabis use disorder dual
diagnosis- clinical vignettes. The 4th International Medical Cannabis Conference. Med
Cannabis and Cannabinoids 2019;2:98.
188. Vasiliu O, Voicu VA, Vasile D. Pharmacological treatment of cannabis use
disorder and schizophrenia spectrum disorders dually diagnosed patients- current state of
research. The 4th International Medical Cannabis Conference. Med Cannabis and
25
189. Vasiliu O, Vasile D, Voicu VA. Cannabis induced panic disorder- a case series.
The 4th International Medical Cannabis Conference. Med Cannabis and Cannabinoids
2019;2:99.
190. Vasiliu O. Thérapie cognitive-comportementale comme stratégie augmentative
dans le traitement des symptômes résiduels de la schizophrénie. Programme Final, P217.
Congrès Français de Psychiatrie, 2019.
191. Vasiliu O. Impact of quetiapine over sleep architecture- a review of current data.
World Sleep Congress. Sleep Medicine 2019;64(Suppl.1):S401.
192. Vasiliu O. Trazodone as add-on for residual insomnia associated to severe major
depressive disorder in elderly patients. World Sleep Congress. Sleep Medicine
2019 ;64(Suppl.1) :S401.
193. Vasiliu O. The use of vasopressin type 1B receptor antagonists as psychotropic
agents- a literature review. 28th European Congress of Psychiatry, 2020. Abstract book,
EPV0453.
194. Vasiliu O. Therapeutic management of anxiety disorders due to multiple
sclerosis. 28th European Congress of Psychiatry, 2020. Abstract book, EPV0113.
195. Vasiliu O. Current evidence-based therapeutic recommendations in narcolepsy.
th
28 European Congress of Psychiatry. Abstract book, EPV1410.
196. Vasiliu O. Case management of vascular depression. 28th European Congress of
Psychiatry, 2020. Abstract book, EPV0820.
197. Vasiliu O. Therapeutic approaches in night eating syndrome- a case series. 28th
European Congress of Psychiatry, 2020. Abstract book, EPV0508.
198. Vasile D, Vasiliu O, Vasiliu DG, Vasile F. Efficacy of the new formulations of
atypical antipsychotics in patients with chronic schizophrenia. 28th European Congress of
199. Vasile D, Vasiliu O. Evaluation of the vagus nerve stimulation in neurocognitive
disorders. 28th European Congress of Psychiatry, 2020. Abstract book, EPV0819
200. Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Candea CA, Tudor C.
Dignity therapy and quality of life in oncologic patients. 28th European Congress of
201. Vasile D, Vasiliu O, Fainarea AF, Patrascu MC, Morariu EA, Stanescu RDA,
Manolache RE, Alexandru IA, Ghenoiu IE, Lecu RA, Gionea M, Gainaru F, Amanolesei I,
Vlaicu RG. Placebo response in clinical trials- how to decrease its negative impact? 28th
European Congress of Psychiatry, 2020. Abstract book, EPV1190.
202. Vasile D, Vasiliu O, Fainarea AF, Patrascu MC, Morariu EA, Stanescu RDA,
Manolache RE, Alexandru IA, Ghenoiu IE, Lecu RA, Gionea M, Gainaru F, Amanolesei I,
Vlaicu RG. Immune-modulation therapy for depressive disorders. 28th European Congress of
Articole in extenso publicate în reviste de specialitate indexate BDI

1. Vasile D, Vasiliu O, Paraschiv S, Lunguţ E, Apetroaei A. Efectul medicaţiei
psihotrope asupra intervalului QTc. Terapeutică, Farmacologie şi Toxicologie Clinică
2004;VIII(2):115-118
2. Vasile D, Gheorghe M, Vasiliu O, Apetroaei A. Antidepresivele cu mecanism dual
versus SSRI în terapia tulburărilor depresive. Jurnalul Român de Psihofarmacologie
2004;4(1,2):25-31
3. Vasile D, Gheorghe M, Apetroaei A, Vasiliu O. Implicaţiile neurobiologice şi
farmacoclinice ale efectului placebo. Jurnalul Roman de Psihofarmacologie 2004;4(1,2):83-
89
4. Vasile D, Vasiliu O, Paraschiv S, Sârbu CA, Gheorghe MD. Comparative Analysis
of the Antipsychotics Side Effects in the Onset of Schizophrenia in Conscripts. Balkan
Military Medical Review 2002;5(1-2):24- 30
26
5. Vasile D, Gheorghe MD, Vasiliu O, Paraschiv S. Factorii deciziei terapeutice- de la
experienţa clinică la studiile farmacologice. Terapeutică, farmacologie şi toxicologie clinică
2004;VIII(4):63-66
6. Vasile D, Gheorghe MD, Vasiliu O, Apetroaei A. Actualităţi neurobiologice şi
farmacoclinice în demenţa Alzheimer. Stetoscop 2005;38:42-43
7. Vasile D, Vasiliu O, Gheorghe M, Ivanov P, Ojog D. Psychotropic Drugs
Discontinuation Syndromes in Clinical Practice. Balkan Military Medical Review 2006;9:38-
41
8. Raceală A, Ivanov P, Vasiliu O. Modificări ale metabolismului glucidic la pacienţii
aflaţi în tratament cu antipsihotice atipice. Jurnalul Român de Diabet, Nutriţie şi Boli
Metabolice 2006; 13(2):121-124
9. Ojog D, Vasiliu O. Improving the quality of life through psychotherapy in
oncologic patients. Modern Psychological Research – trends and prospects, Psihomedia
Publishing House, Sibiu, 2007, 115-117
10. Vasiliu O, Ojog D. Coping mechanism evaluation in chronic schizophrenic
patients. Modern Psychological Research – trends and prospects, Psihomedia Publishing
House, Sibiu, 2007, 129-131
11. Vasiliu O, Ojog D. Cognitive behavioural therapy efficacy in major depression
with histrionic personality disorder comorbidity. Modern Psychological Research – trends
and prospects, Psihomedia Publishing House, Sibiu, 2007, 133-136
12. Ojog D, Vasiliu O. Alteration of body image perception as a side effect to
antipsychotic medication. Modern Psychological Research – trends and prospects,
Psihomedia Publishing House, Sibiu, 2007, 101-102
13. Vasile D, Vasiliu O, Creţu O, Stănescu B, Bădescu E, Băncescu R, Terpan M.
Terapia depresiei la pacienţii oncologici. Medicina Modernă 2008; XV(8):407-412
14. Grigorescu R, Duţu M, Negoiţă S, Vasiliu O, Popescu M, Marinescu S. Relaţia
anxietate- condiţii medicale din ATI. Jurnalul Român de Anestezie Terapie Intensivă 2008;
15(Supl.1):135-136
15. Vasile D, Vasiliu O, Vasile M, Patriche D, Bănică A. Actualităţi şi perspective în
terapia farmacologică a tulburărilor de anxietate. Revista de Medicina Modernă 2008;
XV(9):488-492
16. Vasile D, Vasiliu O. Evaluarea comorbidităţilor psihiatrice în tulburările
somatoforme. Revista de Medicină Militară 2008; 2:3-9.
17. Vasiliu O, Vasile D, Mitrofan N. Evaluarea profilului terapeutic în adicţii. Revista
de Medicină Militară 2008;2:36-44.
18. Vasiliu O, Vasile D, Mitrofan N. Implicaţii clinice ale noilor mijloace de evaluare
terapeutică în adicţii. Revista de Medicină Militară 2008;2:51-61.
19. Vasile D, Vasiliu O, Vasile M, Creţu O. The role of N-Methyl-D-Aspartate
receptors in the psychopharmacology of mood disorders. Therapeutics Pharmacology and
Clinical Toxicology 2008; XII(3):349-353.
20. Vasile D, Vasiliu O, Ojog D. Risperidone long acting administration in type I
bipolar disorder noncompliant patients. Therapeutics, Pharmacology and Clinical Toxicology
2008; 4(XII):489-492.
21. Vasile D, Vasiliu O, Patriche D, Stănescu B, Bădescu E, Vasile M. Sindroame
hepatotoxice asociate medicaţiei psihotrope. Revista de Medicină Modernă 2009;XVI
(4):177-181.
22. Vasile D, Vasiliu O. Cognitive-behavioral therapy efficacy in major depression
with associated axis II risk factor for negative prognosis. Recent Advances in Risk
Management, Assessment and Mitigation, 2010, 460-464
23. Vasile D, Vasiliu O, Ojog DG. Quality of life changes through risk factors
reduction focused psychotherapy in cancer diagnosed patients Recent Advances in Risk
Management, Assessment and Mitigation, 2010, 464-467
27
24. Vasile D, Vasiliu O, Ojog DG. Burn-out in a sample of physicians, nurses and
medical students- risk factors analysis. Recent Advances in Risk Management, Assessment
and Mitigation, 2010, 468-472
25. Vasile D, Vasiliu O, Mangalagiu AG. Cognitive risk factors for releapse in
chronic schizophrenia. Recent Advances in Risk Management, Assessment and Mitigation,
2010, 473-475
26. Vasile D, Vasiliu O, Grigorescu G. Evaluation of the self-aggressive behavior risk
factors in oncologic patients. Recent Advances in Risk Management, Assessment and
Mitigation, 2010, 476-480
27. Vasile D, Vasiliu O, Vasile M. Suicide risk factors assessment in schizophrenia.
Recent Advances in Risk Management, Assessment and Mitigation, 2010, 481-484
28. Vasile D, Vasiliu O, Mangalagiu AG, Ojog DG Augmentation strategies in
selective serotonin reuptake inhibitors resistant obsessive-compulsive disorder- a systematic
literature review. Therapeutics, Pharmacology and Clinical Toxicology 2011;XV(2):83-92
29. Vasile D, Vasiliu O, Mangalagiu AG, Ojog DG. Evaluation of the mood-
stabilizers associated neurocognitive effects in bipolar patients. Therapeutics, Pharmacology
and Clinical Toxicology 2011;XV(4):304-308
30. Vasile D, Vasiliu O, Mangalagiu AG, Sopterean GA, Bratu RE. Comparative
analysis of dual serotoninergic and noradrenergic antidepressants in double depression with
alcohol dependence. Romanian Journal of Psychopharmacology 2013;13(1):7-15
31. Vasiliu O, Vasile D. Comparative analysis of alprazolam, buspirone and
pregabalin as add-on agents in partial responsive generalized anxiety disorder. Romanian
Journal of Psychopharmacology 2015;15(1):26-30.
32. Vasile D, Vasiliu O. The new wave of atypical antipsychotics- Really new drugs
or just another “Me, Too” drugs? Romanian Journal of Psychopharmacology 2015;15(2):83-
91.
33. Patriche D, Vasiliu O, Filip I, Tanase C, Radfar A. Consideratii asupra calității
vietii la pacientii cu dublu diagnostic de tulburare depresiva si dependenta de alcool. Revista
Medicala Romana 2015;LXII (4):339-343.
34. Vasiliu O, Vasile D, Vasiliu DG, Vasile F. Analysis of antidepressant drugs
impact over quality of life in old-age onset depressive disorder. Romanian Journal of
Psychopharmacology 2016;16(1):1-6.
35. Vasiliu O, Voicu V, Vasile D. Pharmacologic treatment in old-age major
depression. A systematic literature review. Romanian Journal of Psychopharmacology
2016;16(2):47-61.
36. Vasiliu O, Vasile D. Mentalization Based Treatment for Behavioral Addictions: A
Conceptual Framework. International Journal of Psychiatry and Psychotherapy 2017;2:45-
49.
37. Vasiliu O, Vasile D. Cognitive-Behavioral Therapy for Internet Gaming Disorder
and Alcohol Use Disorder - A Case Report. International Journal of Psychiatry and
Psychotherapy 2017;2:34-38.
38. Vasiliu O, Vasile D. Food Addiction - A Disorder in Search of Diagnostic
Criteria. International Journal of Psychiatry and Psychotherapy 2017;2: 30-33.
39. Vasiliu O, Vasile D. Treatment of Gambling Disorder - A Systematic Review of
Current Evidence. International Journal of Psychiatry and Psychotherapy 2017;2:22-29.
40. Vasiliu O, Vasile D. Social Network Sites Addiction - A New Challenge for New
Times. International Journal of Internet of Things and Web Services 2017;2: 84-88.
41. Vasiliu O, Vasile D. Analysis of Comorbidities in A Group of Young Patients
Diagnosed with Internet Addiction. International Journal of Internet of Things and Web
Services 2017;2: 80-83.
42. Vasiliu O, Vasile D. Compulsive Buying Disorder: A Review of Current
Data. International Journal of Economics and Management Systems 2017;2: 134-137
28
43. Vasiliu O, Vasile D. Vaccines for Drug Dependence: A Systematic Review of the
Literature. International Journal of Medical Pharmacology 2017;2:1-6
44. Vasiliu O, Vasile D, Vasiliu DG, Vasile F. Cell Phone Addiction: A Review of the
Available Data. International Journal of Communications 2017;2:36-40
45. Vasiliu O, Vasiliu DG, Vasile D. Predictors for treatment response in old age
major depressive disorder. Romanian Journal of Experimental Applied Psychology
2017;8(Special Issue 1):298-302
46. Vasiliu O, Vasiliu DG, Vasile D. Cognitive behaviour therapy in young patients
with alcohol related disorders. Romanian Journal of Experimental Applied Psychology
2017;8(Special Issue 1):303-307
47. Vasiliu DG, Vasiliu O. Health related quality of life evaluation scales in late-life
major depression. Romanian Journal of Experimental Applied Psychology 2017;8(Special
Issue 1):308-313
48. Vasiliu DG, Vasiliu O. Psychotherapeutic approaches in cases of internet
gambling disorder- a case series. Romanian Journal of Experimental Applied Psychology
2017;8(Special Issue 1):314-318
49. Vasiliu O, Marinescu I, Vasile D. Pharmacological therapy of post-stroke
depression. Psihiatru.ro 2019;57(2):18-21
50. Marinescu I, Vasiliu O, Vasile D. Modern approaches in the treatment of
compulsive eating disorders. Psihiatru.ro 2019;57(2):24-31.
51. Marinescu I, Vasiliu O, D.Vasile. Therapeutic management of substance use
disorders (I). Psihiatru.ro 2020;60(1):5-12.
52. Vasiliu O, Marinescu I, Vasile D. Therapeutic management of substance use
disorders (II). Psihiatru.ro 2020;60(1):14-19.
Autor/coautor la realizarea de monografii şi manuale de specialitate

1. Octavian Vasiliu, Victor Voicu, Daniel Vasile. Impactul terapiei farmacologice
asupra calității vieții în depresia geriatrică. Ed. Academiei Române, Bucureşti, 2017; ISBN
978-973-27-2766-9.
2. Daniel Vasile, Octavian Vasiliu. Abordări terapeutice cognitiv-comportamentale în
cazurile de dublu diagnostic depresie- tulburări de personalitate. Editura Printech, Bucureşti,
2007; ISBN 978-973-718-720-8
3. Daniel Vasile, Octavian Vasiliu. Terapia farmacologică a tulburărilor anxioase.
Curs. Editura Printech, Bucureşti, 2008; ISBN 978-606-521-052-3
4. Daniel Vasile, Octavian Vasiliu. Evaluarea şi managementul riscului suicidar în
tulburările de personalitate. Editura Printech, Bucureşti, 2008; ISBN 978-606-521-061-5
5. Daniel Vasile, Octavian Vasiliu. Abordări terapeutice în dependenţa de substanţe.
Editura Printech, Bucureşti, 2009; ISBN 978-606-521-200-8
6. Daniel Vasile, Octavian Vasiliu. Factori de vulnerabilitate în toxicomanii. Editura
Printech, Bucureşti, 2009; ISBN 978-606-521-201-5
7. Daniel Vasile, Octavian Vasiliu. Psihopatologie generală - vol.1. Semiologie.
8. Daniel Vasile, Octavian Vasiliu. Psihopatologie generală - vol.2. Sindromologie.
9. Daniel Vasile, Octavian Vasiliu. Factorii compliantei terapeutice in psihiatrie. Ed.
Printech, Bucureşti, 2009; ISBN 978-606-521-370-8
10. Daniel Vasile, Octavian Vasiliu. Psihofarmacologie clinică interactivă. Teste
comentate. Ed. Printech, București, 2013; ISBN 978-606-23-0099-9
Coordonator de monografii/tratate de specialitate

Victor Nicolaescu, Rodica Hapeci, Octavian Vasiliu, Paula Frusinoiu (coordonatori).
Prevenirea delincvenţei juvenile şi a consumului de droguri în judeţul Buzău. Ed.CISON,
Buzău, 2010; ISBN 978-973-8301-21-4.
29
Cărți publicate de edituri internaționale
1. Octavian Vasiliu, Victor A. Voicu, Daniel Vasile. Quality of Life in Old Age
Depression. Lambert Academic Publishing, 2018; ISBN 978-613-9-82491-5.
2. Octavian Vasiliu, Victor A. Voicu, Daniel Vasile. Étude de la qualité de vie dans la
dépression gériatrique. Éditions Universitaires Européennes, 2018; ISBN 978-620-2-28791-3.
3. Octavian Vasiliu, Victor A. Voicu, Daniel Vasile. Tratamiento farmacológico y
calidad de vida en la depresión geriatrica. Editorial Académica Española, 2018. ISBN 978-
613-9-00594-9.
4. Octavian Vasiliu, Victor A. Voicu, Daniel Vasile. Psicofarmacologia e qualità della
vita nella depressione geriatrica. Edizioni Accademiche Italiane, 2018. ISBN 978-3-639-
65637-4.
Capitole din cărţi de specialitate

1. Vasiliu O, Vasile D, „Aspecte bioetice ale abordării pacientului în psihooncologie”,
în Standarde europene pentru programe postdoctorale competitive de formare în domeniul
managementului cercetării avansate şi expertizei psihiatrice medico-legale, IML Iaşi,
Ed.Timpul, Iaşi, 2013, pp.93-99; ISBN 978-973-612-495-2.
2. Vasiliu O, Vasile D, „Actualități și perspective în farmacoterapia schizofreniei- o
analiză narativă a literaturii”, în D.Marinescu, I.Marinescu (Editori), Trecut, prezent și viitor
în psihiatria românească, Ed. Aius, Craiova, 2018, pp.365-380; ISBN 978-606-562-736-9.
3. Vasiliu O, Ene T, Barca V. „A systematic review on interventions for care and
rehabilitation”, in Anttila H, Frusinoiu P, Mannila S (Editors), Developing prevention, care
and rehabilitation for drug users in Romania. Recommendations based on systematic
literature reviews and search for good practice. Ed. Armanis, Sibiu, 2013, pp.37-62; ISBN
978-606-8595-01-6.
4. Vasiliu O, Ed Ene T, Iancu A, Dima A, Chelaru A, Frusinoiu P, Antilla H.
„Recommendations”, in Anttila H, Frusinoiu P, Mannila S (Editors), Developing prevention,
care and rehabilitation for drug users in Romania. Recommendations based on systematic
literature reviews and search for good practice. Ed. Armanis, Sibiu, 2013, pp.71-75; ISBN
978-606-8595-01-6.
5. Vasiliu O. “Cognitive-behavioral therapy for patients with panic disorder and
comorbid alcohol use disorder- a case series”, in Mind, body and behaviour: new trands and
prospects in health, education and social sciences, Ed. Universitara, Bucuresti, 2019, pp.91-
100; ISBN 978-606-28-0845-7.
6. Vasiliu O. “Psychological mediators of the quality of life in immigrants- a narrative
review”, in Mind, body and behaviour: new trands and prospects in health, education and
social sciences, Ed. Universitara, Bucuresti, 2019, pp.125-132; ISBN 978-606-28-0845-7.
7. Vasiliu O. “Improving quality of life in patients with post-stroke depression
through psychotherapy- a review of current data”, in Mind, body and behaviour: new trands
and prospects in health, education and social sciences, Ed. Universitara, Bucuresti, 2019,
pp.161-168; ISBN 978-606-28-0845-7.
Premii/mentiuni obținute
Premiul Gheorghe Marinescu al Academiei Române -Secția Științe Medicale-
2017- pentru lucrarea ”Impactul terapiei farmacologice asupra calității vieții în depresia
geriatrică”, Ed. Academiei Române, Bucureşti, 2017.
Certificate of Merit for e-Poster Presentation, 23rd World Congress of Social
Psychiatry, Bucharest, 2019
Diplomă de excelență pentru participare cu lucrare științifică la conferința ”Psihiatria
românească între știință și practică. Respectarea drepturilor profesioniștilor din domeniul
sănătății mintale”, București, 2019.
30
The Best Poster Presentation obținut la 11th Congress of Balkan Military
Medical Committee, Athens, Greece, 18-22 June 2006 pentru lucrarea intitulată
”Augmenting antidepressive psychopharmacological approach with cognitive-behavioral
therapy in refractory major depressive disorder”- Vasiliu O, Vasile D, Sarmache M, Vasile
M.
Participare în granturi naționale/internaționale

-Proiect PHARE RO/2006/IB/JH-07- Agenția Națională Antidrog și National Institute
for Health and Welfare din Finlanda, membru în echipa de cercetare a bunelor practici în
domeniul adicțiilor.
-Proiect ECOST CA16207 for Problematic Usage of Internet - contract 1838/2019,
grant de reprezentare la conferințe internaționale.
Participare la studii farmacoclinice- subinvestigator (selectiv)

1. A multi-center, inpatient and ambulatory, phase 2, double blind, randomized,
placebo-controlled proof of concept study of CYR-101 in patients with DSM-IV
schizophrenia. Protocol CYR-101C01, EudraCT 2007-007538-21. 2008-2009.
2. A 52-week, 2-period, multicenter, randomized, double-blind, donepezil-referenced,
placebo-controlled, efficacy and safety study of 3 dosage levels of SAM-531 in outpatients
with mild to moderate Alzheimer disease. Protocol 3193A1-2005-WW/SAM-531,
NCT00895895. Phase IIb, 2009-2010.
3. A randomized, double-blind, placebo-controlled, parallel-group study of
Paliperidone Palmitate evaluating time to relapse in subjects with schizoaffective disorder.
Protocol R092670-SCA-3004, NCT01193153. Phase III, 2010.
4. A phase 3, multicenter, randomized, double-blind, placebo-controlled trial of three
fixed dose of OPC-34712 in the treatment of adults with acute schizophrenia. Protocol 331-
10-231, EudraCT 2011-002538-38. 2011.
5. A long-term, multicenter, open-label trial to evaluate the safety and tolerability of
oral OPC-34712 as maintenance treatment in adults with schizophrenia. Protocol 331-10-237,
EudraCT 2011-002514-37. Phase III, 2011.
6. A randomized, double-blind, placebo-controlled, parallel-group, 12-month trial of
leuco-methylthioninium bis(hydromethanesulfonate) in subjects with mild to moderate
Alzheimer’s Disease. Protocol Trx-237-015, EudraCT 2012-002866-11. Phase II, 2012.
7. A randomized, double-blind, placebo-controlled study to evaluate the efficacy and
safety of low-dose lurasidone in acutely psychotic subjects with schizophrenia. Protocol
D1050303, EudraCT 2012-005271-14. Phase III, 2013.
8. A 52-week, multicenter, randomized, double-blind, placebo-controlled study to
evaluate the efficacy, safety, and tolerability of an intramuscular depot formulation of
aripiprazole (OPC-14597) as maintenance treatment in patients with bipolar I disorder.
Protocol 31-08-250, EudraCT 2012-002870-30. Phase III, 2013.
9. A 52-week, multicenter, open-label study to evaluate the effectiveness of an
intramuscular depot formulation of aripiprazole (OPC-14597) as maintenance treatment in
patients with bipolar I bipolar. Protocol 31-08-252, EudraCT 2012-004334-42. Phase III,
2013.
10. ADAMANT- A 24-months randomized, placebo-controlled, parallel-group,
double blinded, multicenter, phase 2 study to assess safety and efficacy of AADvac1 applied
to patients with mild Alzheimer’s disease. Protocol AC-AD-003, EudraCT 2015-000630-30.
Phase II, 2016.
11. A randomized, double blind, placebo-controlled, parallel group, comparative,
multicenter, phase 2 clinical study to evaluate efficacy and safety of two doses of
LND101001 monotherapy in patients with mild to moderate Alzheimer’s disease. Protocol
LRP/LND101001/2013/001, EudraCT 2013-001851-11. 2015-2016.
31
12. A 6-week, randomized, double-blind, placebo-controlled study to evaluate the
efficacy and safety of lurasidone (SM-13496) in acutely psychotic subjects with
schizophrenia. Protocol D1001066, EudraCT 2016-000060-42. Phase III, 2016-2018.
13. A 12-week, open-label extension study of lurasidone (SM-13496) in subjects with
schizophrenia. Protocol D1001067, EudraCT 2016-000061-23. Phase III, 2016-2018.
14. A 4-week, randomized, double-blind, parallel-group, placebo-controlled, flexibly-
dosed, multicenter study to evaluate the efficacy and safety of SEP-363856 in acutely
psychotic adult subjects with schizophrenia. Protocol SEP361-201, EudraCT 2016-001555-
41. Phase II, 2016-2018.
15. A 26-week open-label safety and tolerability extension study of SEP-363856 in
adult subjects with schizophrenia. Protocol SEP361-202, EudraCT 2016-001556-21. Phase II,
2016-2018.
16. A phase 3, randomized, double-blind, placebo-controlled, parallel-group,
multicenter, fixed-dose clinical trial evaluating the efficacy, safety, and tolerability of
cariprazine in the prevention of relapse in bipolar I disorder patients whose current or most
recent episode is manic, with or without mixed features. Protocol RGH-MD-53, EudraCT
2016-000756-98. Phase III, 2016-2018.
Participare la studii farmacoclinice- investigator principal

BPD-ChronoS-Retrospective data collection from BPD patients treated for at least 3
months with Depakine Chrono, after Switch from other valproate treatments. Protocol
VALNA_L_02679. Studiu clinic național, retrospectiv, multicentric, non-intervențional.
Participare la programe educaționale, în calitate de consultant (selectiv)

”Experiența în studii de caz”, 13.12.2011, București, Bristol Myers Squibb
”Diferența pentru pacienții depresivi hipertensivi”, 27.03.2013, București, Servier
Pharma
”Depresia și factorii de risc la pacienții cu comorbidități cardiovasculare”,
19.11.2013, București, Servier Pharma
”Noi perspective în tratamentul depresiei”, 20.02.2014, București, Servier Pharma
Reviewer/Editor
1. Reviewer pentru Romanian Journal of Military Medicine
ISSN-L1222-5126; eISSN 2501-2312; pISSN 1222-5126
2. Editor al Psychiatry and Psychotherapy
DOI: 10.31579/JPP/2018
3. Editor al Neuroscience and Neurological Surgery
ISSN Online: 2578-8868
Membru în asociaţii de specialitate:

-Asociatia Română de Terapie Cognitivă şi Comportamentală- din noiembrie 2002;
-Colegiul Psihologilor din România- din iunie 2005;
-European Psychiatric Association- din mai 2017;
-European College of Neuropsychopharmacology- din mai 2017;
-International Society for Bipolar Disorders- din mai 2017;
-International Early Psychosis Association- din iulie 2017;
-World Scientific and Engineering Academy and Society- din iunie 2017;
-Schizophrenia International Research Society- din februarie 2018 ;
-American Psychological Association- din aprilie 2018;
-American Psychiatric Association- din aprilie 2018;
-International Society for the Study of Behavioral Addictions- din noiembrie 2018;
-World Sleep Society- din martie 2019;
-World Association on Dual Disorders- din martie 2019.
32
Membru în comisii cu profil medical
-Comisia Locală de Etică a Spitalului Universitar de Urgență Militar Central
”Dr.Carol Davila”, București, 2012-2019.
Limbi străine cunoscute

(conform Cadrului European Comun de Referință pentru Limbi Străine)
Înțelegere Vorbire Scriere

Ascultare Citire Participare la Discurs oral
conversație
*
Engleză C1 C1 C1 C1 C1
Franceză* B2 B2 B2 B2 B2
Spaniolă B1 B1 B1 B1 B1
Germană B1 B1 B1 B1 B1
**
Mandarină B2 B2 B1 B1 B2
*
Certificat de traducător Seria E Nr. 2203/16.09.2019 profilul Medicina - Farmacie eliberat
de Ministerul Culturii și Identității Naționale din România
**
Atestat HSK4, no. H41705037072- Institutul Confucius-20.05.2017
Adresă de contact
-email: octavvasiliu@yahoo.com
33

CV Col. Medic Dr. Octavian Vasiliu Mai 2020

Încărcat de

Informații document

Titlu original

Drepturi de autor

Formate disponibile

Partajați acest document

Partajați sau inserați document

Opțiuni de partajare

Vi se pare util acest document?

Este necorespunzător acest conținut?

Drepturi de autor:

Formate disponibile

CV Col. Medic Dr. Octavian Vasiliu Mai 2020

Încărcat de

Drepturi de autor:

Formate disponibile

CURRICULUM VITAE

Data şi locul nașterii

Instituția de învățământ Tipul diplomei Durata studiilor

Stagii de pregătire profesională și specializări

Stagii, workshop-uri şi cursuri postuniversitare finalizate

Participări la congrese naţionale şi internaţionale cu tematică medicală

Participări la conferinţe şi congrese de Psihologie

Lucrări indexate Thomson Reuters - Web of Science Core Collection - în rezumat

Lucrări in-extenso indexate Thomson Reuters - Web of Science Core Collection

Lucrări prezentate la congrese și conferințe naționale și internaționale, publicate în

Articole in extenso publicate în reviste de specialitate indexate BDI

Autor/coautor la realizarea de monografii şi manuale de specialitate

Coordonator de monografii/tratate de specialitate

Capitole din cărţi de specialitate

Participare în granturi naționale/internaționale

Participare la studii farmacoclinice- subinvestigator (selectiv)

Participare la studii farmacoclinice- investigator principal

Participare la programe educaționale, în calitate de consultant (selectiv)

Membru în asociaţii de specialitate:

Limbi străine cunoscute

Înțelegere Vorbire Scriere

S-ar putea să vă placă și